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Abstract
Point Mutations or translocation in NSD1 cause the overgrowth disorder Sotos syndrome
and acute myeloid leukemia (AML), respectively (Berdasco M. et al, 2009, Wang G et al,
2003).  NSD1  contains  several  chromatin  related  domains  including  a  SET  domain
responsible  for  histone  methyltranferases  activity  (H3K36  and  H4K20),  two  nuclear
receptor-interaction (NID) motifs, five zinc finger domains (PHD1-5), a variant PHD finger
(C5HCH), two proline-tryptophan-proline-tryptophan (PWWP1-2) domains (Lucio-Eterovic
AK,  et  al ,  2011),  suggesting  a  role in  chromatin regulation  and  gene  expression.  20
pathological Sotos mutations have been detected on the PHD tandem domain composed by
NSD1-PHD5 and NSD1-C5HCH  (NSD1-P5C5). The tandem domain is essential for the
pathogenesis  of  acute  myeloid  leukaemia  (AML)  caused  by  the  chimeric  protein
NUP98/NSD1 that forces the abnormal activation of Hox-A and Meis1 genes (Wang at al
2007). The deletion of this tandem domain is sufficient to abolish NUP98/NSD1 interaction
with  chromatin,  preventing  both  the  transcription  activation  of  HOX genes  and  the
immortalization of myeloid progenitors. The biological role of NSD1-P5C5 is still unclear.
It was proposed that this tandem domain is involved in the recognition of both H3K4me3
and H3K9me3 histone marks, (Pasillas M et al. 2011). However, biophysical experiments in
our laboratory did not confirm these results challenging the idea that this tandem domain
can really work as epigenetic reader. Previous biochemical studies suggested that NSD1-
P5C5 can also  work  as  protein-protein  interaction  motif,  being  able  to  bind  to  the  co-
repressor  Nizp1  by  its  C2HR  zinc  fingers  motif  (Nizp1-C2HR)  thus  mediating  gene
repression (Nielsen AL et al, 2004). 
The structural determinants of this interaction are still unknown and have been object  of
this thesis.  In order to get more insights into the physiological and pathological role of
NSD1-P5C5,  we  have  solved  its  (i)  solution  structure  by  NMR  spectroscopy  and  (ii)
characterized its interaction with Nizp1-C2HR.
NSD1-P5C5  folds  as  unique  functional  unit  adopting  a  “face  to  side  orientation”.  In
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particular NSD1-PHD5 (or NSD1-P5) presents the canonical PHD finger fold, whereas the
NSD1-C5HCH (or NSD1-C5) domain displays an atypical topology characterized by the
presence of an additional two stranded β-sheet. In order to investigate the impact of Sotos
point mutation on NSD1-P5C5 we expressed and purified seven mutants and analyzed them
by NMR.  The  majority  of  them destabilize  the  fold,  with  the  exception  of  the  solvent
exposed  mutation  Arg2152Gln  and  His2205Arg  suggesting  a  functional  role  for  these
residues. 
We next solved the solution structure of the zinc finger Nizp1-C2HR, an atypical Cys2His2-
type zinc finger  in which the fourth zinc chelating residue is substituted by an arginine
residue. Its fold consists of a short α-helix and of a short two-stranded β-sheet hold together
by one zinc ion. Importantly, we showed that three zinc ligands are sufficient to maintain the
protein domain fold and functionality. 
NMR titrations  of  15N labelled  NSD1-P5C5 with  Nizp1-C2HR and  15N labelled Nizp1-
C2HR with NSD1-P5C5 clearly show that the two proteins directly interact. Analysis of the
chemical shift displacements upon complex formation allowed to identify the residues of the
two protein  domains  involved in   protein-protein  interaction.  The  interaction  surface  is
located on the interface between NSD1-P5 and NSD1-C5 and on the  α-helix of  Nizp1-
C2HR, respectively. 
Based on this information using the software HADDOCK we have computed a data driven
docking model  of the protein complex. In the model Nizp1-C2HR places its α-helix in the
groove at the interface between NSD1-P5 and NSD1-C5,  creating both hydrophobic and
polar intermolecular contacts. 
The  thermodynamic  parameters  that  govern  complex  formation  were  studied  by  ITC
titrations: the binding reaction is entropy-driven, with a stoichiometry of 1:1 and a Kd of
3,80±0,66  μM. In  order  to  solve  the  structure  of  the  protein  complex  we  performed
crystallographic screenings, and we have found preliminary conditions for obtaining single
crystals. 
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In conclusion, the presented results provide novel information on the interaction between a
tandem PHD finger domain and zinc finger motif. The results represent, to the best of our
knowledge, the first biophysical characterization between two zinc binding domains. Most
importantly, these data give the first molecular details of the interaction between NSD1 and
Nizp1  and  may  provide  useful  insights  into  the  function  of  NSD1  and  its  role  in
pathological conditions both in Sotos Syndrome and AML. Future work will be dedicated to
the  full  three-dimensional  characterization of  the  complex and to  the  analysis  of  Sotos
mutations on complex formation. 
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1.Introduction
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1.1 Epigenetic
In the eukaryotic  organism, all cells inherit the same genetic material, and their ability to maintain
specific physical characteristics and biological functions of tissues and organs is due to heritable
differences in the packaging of DNA and chromatin (Adwan and Zawia 2013). These differences
dictate distinct cellular gene expression programs but do not involve changes in the underlying
DNA sequence of the organism (Arrowsmith et al. 2012). Epigenetics (which literally means ‘above
genetics’) underpins the fundamental basis of human physiology and it deals with acquired and
heritable modifications on DNA and histone residues that regulate the expression and functions of
genes (Patel and Wang 2013). 
These modifications include DNA methylation and hydroxymethylation, histone modifications and
non-coding  RNA  regulation.  Histone  modifications  consist  of  acetylation,  methylation,
crotonylation,  ubiquitination,  sumoylation,  phosphorylation,  hydroxylation  and  proline
isomerization  (Davie  and  Spencer  1999;  Tony  Kouzarides  2007;  Peterson  and  Laniel  2004).
Epigenetic  changes  are  dynamic  and  they  are  responsible  for  orchestrating  the  myriad
transcriptional units, condensed chromatin clusters and other features that distinguish the various
cell types and the states of development or disease that share a genome within an individual.
Epigenetics is of therapeutic relevance in multiple diseases such as cancer, inflammation, metabolic
disease and neuropsychiatric disorders. The dynamic nature of epigenetics means that it may be
possible to alter disease-associated epigenetic states through direct manipulation of the molecular
factors involved in this process (Adwan and Zawia 2013; Jakovcevski and Akbarian 2012).
1.2 Chromatin organization
The epigenetic changes alter chromatin organization (Fig 1).  The basic unit of chromatin is the
nucleosome, which consists of 146 base pairs (bp) of genomic DNA wrapped around an octamer
composed of the core histones H2A, H2B, H3 and H4, with the histone tails  containing  post-
translational modifications (PTMs) (Baxevanis and Landsman 1996).
Histone  post-translational  modification  is  mediated  by  two  antagonizing  sets  of  enzymatic
complexes: the “writer”(such as methyltranferase and acetyltranferase enzyme)  and “eraser” (such
as  histone  deacetylases  and  lysine  demethylases),  proteins  and  associated  factors  that  site-
specifically attach and remove the modifications, respectively. Usually these modifications occur on
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the N-terminal tails of the histones H3 and H4, that protrude out of the  nucleosome from the lateral
surfaces (Luger et al. 1997). These PTMs compose an “epigenetic code” and serve as scaffolds for
reader modules (such as PHD finger, bromodomain, chromo domains etc..), which in turn dictate
the ordered recruitment of non-histone proteins and enzymes (Patel e Wang 2013) that alter the
physical  structure  of  the  chromatin and control  the  gene expression (Patel  e  Wang 2013).  The
misinterpretation of these epigenetic markers lead to inappropriate expression or silencing of gene
programs (Bakeret et al. 2008).
Fig 1. Nucleosome organization (adopted from Arrowsmith
et al. 2012). DNA is packaged into chromatin by wrapping
around histone proteins (two copies each of histones H2A,
H2B, H3 and H4) to form a nucleosome. Nucleosomes are
further  compacted  by  additional  protein  factors  to  form
chromatin, with the degree of compactness dependent on
the types of post-translational modification present on the
chromatin, with the degree of compactness dependent on
the types of post-translational modification present on the
histones,  especially  on  their  terminal  residues,  which
protrude from the nucleosome particle.
1.3 Chromatin organization in human diseases 
Disordered chromatin organization and function have been ascribed key pathogenic roles in several
human syndromes. These disorder are associated  with the mutations in single genes that encode
DNA methyltransferase and histone modifying enzymes or their  ‘reader’ protein (Jakovcevski e
Akbarian 2012). In the Table 1 are reported several examples of human disorders correlated with
mutation of epigenetic modules.
While  physiological  role  of  catalytic  enzymes  that  mediate  the  addition or  removal  of  histone
modifications is well characterized, in the last years several studies have been focused on the reader
proteins. Determining the regulatory roles of these motifs in the context of human disease will allow
for  a  more  thorough understanding of  normal  and pathological  development,  and may provide
innovative therapeutic strategies wherein “chromatin readers” stand as potential drug targets.
Recently, the Plant Homeodomain (PHD) finger is emerging as a versatile reader module that has a
crucial  role  in  chromatin organization and in a variety of diseases including immunodeficiency
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syndrome,  solid  and blood cancers,  and neurological  disorders  (Baker  et  al  2008).  In  the  next
chapter we will summarize the principal biological and structural characteristics of these protein
domains.
Gene Function Syndrome 
ATRX (Xq21.1) Replication-independent nucleosome remodeling 
and histone H3.3 incorporation
Alpha-thalassaemia, X-linked with mental 
retardation (ATRX), autism
CREBBP (16p13.3) and  
EP300 (22q13.2) 
Transcriptional co-activator, histone acetyl-
transferase
Rubinstein-Taybi syndrome (RSTS) 1 and 2
DNMT1 (19p13.2) DNA methyltransferase. Disease mutations are 
associated with hypomethylated repeats and 
promoters
Hereditary hensory and autonomic neuropathy 
type 1 with adult-onset dementia (HSAN1E)5, 
autosomal dominant cerebellar ataxia, deafness 
and narcolepsy (ADCA-DN)
DNMT3B (20q11.21) DNA methyltransferase. Disease mutations are 
associated with hypomethylation of pericentric 
repeats
Immunodeficiency, centromere instability, 
facial anomalies (ICF1)
ZBTB24 (6q21) Transcriptional repressor and regulator of DNA 
methylation at pericentric repeats
Immunodeficiency, centromere Instability, 
facial anomalies (ICF2) mental retardation 
syndrome
KDM5C (Xp11.22) Histone H3-lysine 4 demethylase X-linked mental retardation, autism
EHMT1 (9q34.3) Histone H3-lysine 9 methyltransferase Kleefstra (mental retardation) syndrome109, 
schizophrenia110, non- specific psychiatric 
phenotypes and neurodegenerative disease in 
post- adolescence period
 NSD1  (5q35.2-q35.3) Histone H3-lysine 36 and H4- lysine 20 
methyltransferase
Sotos (mental retardation) syndrome
PHF8 (Xp11.22) Histone H3-lysine 9 demethylase and 
transcriptional activator
X-linked mental retardation withoutcleft lip 
and/or palate (Siderius-Hamel)
RSK2 (Xp22.12) Serine/threonine kinase (of both histones and 
non-histone proteins)
Coffin-Lowry X-linked mental retardation 
syndrome
MECP2 (Xq28) Methyl CpG binding protein Rett and other neurodevelopmental syndromes, 
autism
Table 1. Human disorders correlated with mutation of epigenetic modules 
1.4 The PHD finger domain
1.4.1 Structural characterization of the PHD finger domain 
The PHD finger is  a  small  protein domain of 50–80 amino acid residues of diverse sequences
containing a zinc-binding motif that appears in many chromatin-associated proteins (Sanchez and
Zhou 2011). Its fold is composed by a two-stranded β-sheet supplemented by one or more helical
segments  and it is stabilized by a pair of Zn ions coordinated to a Cys4-His-Cys3 segment (Fig 2).
Three loops (L1, L2 and L3), variable in length and residue composition, constitute the rest of the
domain. The structure of the fold is maintained by the presence of the Zinc ions: mutations targeting
the Zinc coordinating residues have detrimental effects on the structure of the domain, and thus on
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the correct protein activity (Baker et al. 2008). Conserved hydrophobic residues establish non polar
interactions that further stabilize the structure around a well conserved tryptophan residue (Musco
and Peterson, 2008).
Fig 2. All PHD fingers adopt the same basic topology. Zinc atoms are
shown as gray spheres,  with Zinc-coordinating residues indicated as
large uppercase  letters.  The two core  β-strands  are  shown in green.
Regions that adopt an α-helical conformation in some PHD fingers are
indicated with α. 
1.4.2 The PHD fingers are epigenetic reader domains
PHD fingers can read the N-terminal tail  of histone H3, mainly the methylation state  of H3K4
(K4me0 vs K4me3/2), and to a smaller extent the methylation state of H3R2 (R2me0 vs R2me2)
and tri-methylated H3K9 and the acetylation state of H3K14  (Sanchez and Zhou 2011; Zeng et al.
2010). Binding of yeast PHD fingers to methylated H3K36 has also been reported (Shi et al. 2007).
The reading of H3K4 and H3R2 occurs on a single PHD finger, but at distinct sites. By contrast, the
H3K14 reading occurs in conjunction with the reading of H3K4 and H3R2, in a tandem PHD finger
of  DPF3b  (D4,  zinc  and  double  PHD  fingers,  family  3  protein),  where  the  first  PHD  reads
H3K14ac, and the second PHD reads H3K4me0 and H3R2me0 (Zeng et al. 2010).
Common elements are shared by all histone binding PHD fingers for which structural  data  are
available. These domains bind the first six N-terminal residues of H3 (ARTKQT) on the surface of
the PHD finger through the formation of an anti-parallel β-strand to the two-strand β- sheet (β1 and
β2) of the PHD finger (Fig 5).  The backbone amide of A1 is clamped by the backbone carbonyl
oxygens of residues in the L3 stretch, that most often contain a Pro-X-Gly-X-Trp motif (where X is
any residue). The backbone amide and carbonyl groups of residues R2, T3 and K4 of H3 form
hydrogen bonds with the β1 strand backbone. This β-strand conformation orients R2 and K4 into
two distinct pockets separated by a highly conserved Trp residue. In general, binding of the H3 tail
does not seem to induce significant conformational changes in the PHD finger (Sanchez and Zhou
2011). PHD fingers have been divided into several subgroups, depending on the post-translational
modification selectively recognized. In the following, I will briefly describe these classes of PHD
finger domains.
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1.4.2.1 Reading H3K4me3
Several  structures  of  PHD domains  in  complex  with  H3K4me3 are  available.  The  binding,  as
mentioned  above,  of H3K4me3 occurs through an “aromatic cage” (Fig 3) where the trimethyl
ammonium group  is  stabilized  by  van  der  Waals,  cation–π  and  hydrophobic  interactions.   In
general, residues that are used to form the aromatic cage tend to exist in parts of the structure that
are relatively rigid, such as the  β-strands, or close to the Zn-coordinating Cys residues (Mellor
2006). The simplest aromatic cage observed so far is that of jumonji, AT-rich interactive domain 1A
(JARID1A), which is composed of only two Trp residues (Wang et al. 2009). A slight variation in
the H3K4 binding region is observed in the PHD fingers of yeast homolog of mammalian ING1
(Yng1)  (Taverna  et  al.  2006),  transcription  initiation  factor  TFIID subunit  3  (TAF3),  pygopus
homolog 1 (PYGO) (Miller et al. 2013), inhibitor of growth protein 4 (ING4)  (Hung et al. 2009)
and other PHD fingers of the ING family that have charged (Asp) or hydrophilic (Ser) residues in
close proximity to the H3K4 residue. The presence of charge residue shift the affinity in favor of the
dimethylated form of K4. However, the biological impact of these small differences in affinity is
not clear. 
Fig 3.  PHD fingers specifically recognize and bind to the methylated-H3K4 (H3K4me3). Adopted
from  Baker et al 2008. 
1.4.2.2   Reading H3K4me0
A second subclass of PHD fingers specifically binds histone H3 tail  presenting the unmodified
H3K4 state (K4me0) (Fig 4). These class of PHD fingers include the modules of BRAF35–HDAC
complex protein (BHC80) (Lan 2007, 80), autoimmune regulator (AIRE) (Chignola et al. 2009),
tripartite  motif-containing  protein  24  (TRIM24)  (Hung et  al.  2009,  24)  and DNA (cytosine-5-
methyltransferase 3-like protein, DNMT3L) (Ooi et al. 2007). The binding of K4me0 is achieved by
a combination of acidic and hydrophobic residues that replace the aromatic cage. The interaction is
abrogated by the methylation of H3K4.  Similar to the H3K4me3-binding PHD fingers, the histone
H3 tail also forms a b-sheet with the b- strands in the H3K4me0-binding PHD fingers. 
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Fig 4. PHD fingers specifically recognize and bind to the unmodified-H3K4 (H3K4me0).
Adopted from  Baker et al 2008. 
To this class  belongs the PHD domain that displays a higher affinity to H3K9me3 with respect to
H3K9me0.  This  the  case  of  the  second  PHD  finger  of  Chromodomain-helicase-DNA binding
protein 4 (CHD4), in which the exposed phenylalanine side-chain forms cation-π interactions with
the side chain trimethylammonium moiety of H3K9 (Mansfield et al. 2011). The examples proposed
show that PHD finger domains can function individually and read a single epigenetic  markers.
Recently,  it  has  been shown that the association of two PHD finger domains can read specific
combination of post-translational marks. In the next paragraph, I will present the cases of tandem
PHD fingers that work as unique functional unit recognizing two post-translational markers.
1.4.2.3   Combinatorial reading
The tandem PHD finger of DPF3b was shown to bind H3 unmodified at K4 and acetylated at K14
(H3K14ac) (Zeng et al. 2010). This was the first case of a PHD finger that binds an acetylated
lysine, a post-translational modification usually recognized by bromodomains. The NMR structure
of the DPF3b-PHD12 bound to H3K14ac shows that the two domains have a typical PHD finger
fold and they are oriented one against the other in a face-to-back direction with the H3 peptide
binding across the combined domains (see Fig. 5). The first PHD finger (PHD1) in the DPF3b
tandem binds H3K14ac through a hydrophobic pocket situated on the opposite site of the central β-
sheet. The second PHD finger (PHD2) recognizes the unmodified H3 Arg2 and Lys4 (Fig 5) and the
histone assumes the classical β-strand conformation. The PHD2 is similar to the H3K4me0-binding
PHD  fingers  (BHC80,  AIRE,  DNMT3L):  it  is  characterized  by   the  presence  of  acidic  and
hydrophobic residues that form the H3K4me0 binding pocket.  In this study, the authors show that
the tandem PHD12 finger of DPF3b works as one functional unit and the binding is modulated by
two different  modifications: it is promoted by acetylation at H3K14 (by PHD1) and inhibited by
methylation  at  H3K4 (by  PHD2).  Thus,  the  recognition  of  acetylated  K14 is  fundamental  for
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recruitment  of  the  transcription factor  involved in  gene  activation during the  heart  and muscle
development.    
Fig 5. Three-dimensional structure of the tandem PHD finger of human DPF3b. Ribbon diagram depicting the average minimized NMR structure of
the PHD12 finger bound to an H3K14ac peptide (yellow) in front and top views. The zinc atoms are highlighted as red spheres (in the first two picture
from the left).  In the third picture, space-filled PHD12 structure, highlighting the H3K14ac peptide (yellow) bound across the unified structure of
PHD1 (green) and PHD2 (blue). (Adopted from Zeng et al. 2010 ).
The tandem PHD finger of MOZ regulator factor  (Dreveny et  al.  2014) has a highl  homology
sequence  with  the  double  PHD finger  of  DPF3b,  but  it  recognizes  the  acetylated  H3K14 in a
different manner (Fig 6). Additionally, the MOZ tandem PHD finger is  an example of how the
chromatin  regulator  domains  can  modulate  the  structure  of  H3  histone  tail  and  recognize  in
combinatorial way different post-translational modifications (Fig 7). 
The  histone  tails  adopt  an  unusual  α-helical  conformation,  revealing  a  unique  mode  of  H3
recognition. In the crystal, the two PHD fingers  show a typical globular domain and the histone
binding  site  is  localized  at  the  domains interface,  stabilized  by  salt  bridges and  hydrophobic
contacts. The helical structure of the H3 histone tail directs the recruitment of epigenetic marks.
The side chain of H3A1 inserts into a hydrophobic pocket formed by P-X-G-X-W motive and the
H3 Arg2 engages in a network of hydrogen bonding and electrostatic interactions with two aspartate
residues on the second PHD domain. Interestingly, H3 Lys4 engages in direct hydrophobic and
hydrogen  bonding  interactions  with  residues  at  the  interface,  and  in  this  conformation   the
metylation of the K4 abolishes the binding with H3 histone tail. The K9 is exposed and located on
the opposite site with respect to K4, it  has no impact on the structure of histone tails and it is
accessible for other modification. The acetylated H3K14 side chain is insert in preformed pocket on
the  first  PHD finger  surface:  this  pocket  is  mainly  hydrophobic  and  exhibits  a  weak  positive
electrostatic potential, that is not appropriate for unmodified K14 interaction. 
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Fig 6. Structure of  the MOZ DPF domain.  The PHD1 and PHD2 subdomains are
colored in turquoise and blue, respectively. Residues engaged in interactions with the
N-terminal  helix  α1  and  PHD2 as  well  as  a  direct  hydrogen  bonding  interaction
between PHD1 and PHD2 are labelled and shown in stick representation. (Adopted
from Dreveny et al 2013)
Fig 7. Structural basis of  H3K14ac recognition by MOZ. Surface representation of the
MOZ  DPF  domain  coloured  according  to  electrostatic  potential  in  complex  with
H3K14ac in red cartoon representation. (Adopted from Dreveny et al 2013)
PHD fingers are versatile chromatin regulator domain with diversified functions. For example, the
KAP1 (KRAB-ZFP–associated protein 1) PHD finger is associated with  a bromodomain and it acts
as a SUMO E3 ligase (Ivanov et al. 2007). Other PHD fingers were shown to bind simultaneously
histone and non-histone partners, such as the Pygo PHD. This domain is a histone H3K4me2/3
reader that simultaneously associates with the histone H3 tail and the HD1 domain of the BCL9/Lgs
proteins  using  a  different  binding surface.  This ternary  complex mediates  a  cross-talk between
epigenetic  and  non  epigenetic  cellular  signalling  pathways  that  is  important  to  transduce  Wnt
signalling (T. C. R. Miller et al. 2013). 
In my PhD thesis I have focused my attention on Nuclear receptor binding SET domain protein 1
(NSD1) (Morishita and di Luccio 2011; Lucio-Eterovic et al. 2010). This protein contains 6  PHD
finger  that  are  strictly  associated  suggesting  that  they  function  in  cooperative  manner  and  as
structural hubs for the recruitment of non-histone protein and epigenetic markers. Deletion, point
mutations that involve these PHD fingers cause Sotos syndrome (Pasillas et  al.   2011),  a rare
genetic disorder. When fused to NUP98, NSD1 is involved in acute myeloid leukemia (AML), and
its  PHD finger domains seem to play a role in aberrant gene expression (Wang et al. 2007). In the
next chapter I will  describe the biological role of NSD1, and how its PHD finger domains are
involved in physiological functions and  in  pathological condition.
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1.5 NSD1
NSD1  is a nuclear protein involved in the  regulation of the chromatin structure. It is essential for
the development of mouse embryos and disruption of the  Nsd1 gene led to failure in the post-
implantation development (Rayasam et al. 2003). It was found for the first time in a series of yeast
two-hybrid assays as a nuclear receptor interactor exhibiting properties ascribed to both coactivators
and corepressors  (Huang et  al.  1998).  It  displays  lysine  methyltransferases  activity  by its  SET
domain (Rayasam et al. 2003) and it contains domains typical of molecules involved in chromatin
regulation  two  proline-tryptophan-tryptophan-proline  (PWWP)  domains  (PWWP1-2),  and  five
classical plant homeodomains (PHDI-V) and a degenerate one (C5HCH) (Morishita and di Luccio
2011) (Fig 8).
Fig 8. Functional domains contenting in NSD1.
In mouse were two isoforms of NSD1 protein were detected. The first isoform, from the mouse
embryo tissues lacks the  PWWP1 while the second isoform in the mouse brain tissues  contains
both the PWWP domains (Huang et al. 1998; Kurotaki et al. 2001).  Kurotaki et al.  were the first to
describe the human homologue of the murine Nsd1 gene. About NSD1  methyltranferases activity,
in vitro enzymatic assays showed poor selectivity towards all the core histones (H3, H2A, H2B and
H4).  When nucleosomes were used as a substrate, the SET domain acted as a selective H3K36
dimethylase. Interestingly, this selectivity could be increased by short DNA fragments in a dose-
dependent  manner,  indicating  that  the  effect  of  DNA on NSD1 methyltransferase  selectivity  is
independent of the formation of nucleosomes (Li et al. 2009; Qiao et al. 2011). Mass spectrometry
experiments show that NSD1 is an interactor of H3K36me3. This epigenetic mark is a signal for
gene activation (Vermeulen et al. 2007). Biochemical studies (GST-pull down) suggest that the fifth
PHD finger domains recognize both the methylated K4 and K9 on histone tail 3, two epigenetic
marks, which usually lead to opposite outcomes, gene activation and gene repression, respectively
(Pasillas et al. 2011). Nielsen  et al  identified Nipz1 (NSD1-interacting zinc finger protein 1) as
interactor of NSD1. Nizp1 harbours a transcriptional repression domain, for which NSD1 seems to
act as a corepressor, and it contains two cluster of Cys-Cys-His-His zinc finger domains that in this
conformation display DNA and protein interaction activity. Interestingly, two hybrid assays revel
that the tandem domain of NSD1 composed by PHD5 and C5HCH domain recognizes the Cys-Cys-
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His-Arg (C2HR) motif of Nizp1, a degenerate copy of the zinc finger motifs. 
These  features  revel  a  bifunctional  role  for  NSD1  that  can  positively  and  negatively  regulate
transcription depending on the cellular context. In the HCT116 colorectal cancer cells NSD1 binds
near various promoter elements and regulates multiple genes involved in various processes (Lucio-
Eterovic et al. 2010). In particular, the Chip microarray revels that there are over 300 candidate
NSD1 targets in HCT116 cells.  This includes  genes implicated in cancer: Bone morphogenetic
protein 4 (BMP4),  Cathepsin D (CTSD),  and Kruppel-like  factor  6 (KLF6),  von Hippel  tumor
suppressor (VHL), and Kallikreins KLK6 and KLK14. Additionally, several cell cycle-related genes
were identified: CDK4, CDC6, CHEK1, CCNE1 (cyclin E), CDKN2A, and the cyclin B interacting
protein CCNB1IP1. It was found that NSD1 binds to the promoter regions of 20 different keratin
genes, including two (KRT3 and KRT6B) known to be regulated by the p65 subunit of NF-κB.
Moreover,  it  was  identified the p65 targets  SLC16A1,  IGF2BP2 as  a  possible  NSD1-regulated
genes. The genes involved in the development and mental retardation candidate gene (ZMYM3)
are  also  potential  targets  of  NSD1.  NSD1 regulates  target  gene  expression  in  a  tissue-specific
manner.  For example the knockdown of NSD1 in MCF-7 breast cancer cells reduce the levels  of
the KRT10 transcripts,  while  in HCT116 cells  the expression of these gene are independent  of
NSD1 function. Additionally, in U2OS osteosarcoma cells the ZFP36L1/TPP transcript levels were
significantly abrogated, but they were modestly affected in NSD1-deficient HCT116 cells (Lucio-
Eterovic  et  al.  2010).  NSD1  binds  the  promoter  region  of  BMP4  gene  and  promotes
H3K36methylation in this region. H3K36 trimethylation is required for the recruitment of RNA
polymerase II to the BMP4 gene promoter and for transcriptional elongation (Berdasco et al. 2009).
In pathological conditions, such as the Sotos Syndrome (see chapter 1.41), the bone morphogenesis
is strongly perturbed. 
1.5.1 NSD1 in human disease: the case of Sotos Syndrome and Acute M  yeloid Leukemia (AML)
The physiological role of NSD1 is largely unknown. In this paragraph I will summarize the diseases
in which NSD1 is involved.
It has been shown that NSD1 is involved in positive regulation of Hox genes: in fact knockout of
Nsd1 in  mice produces  developmental  defects and precludes expression of HoxA1 and HoxB1
(Rayasam et al. 2003). 
The acute myeloid leukemia (AML) disease is characterized by uncontrolled expansion of myeloid-
lineage progenitors, HoxA7, HoxA9 and HoxA10 are overexpressed with Meis1, a Hox cofactor
gene. About 5% of human AMLs harbour the t(5;11)(q35;p15.5) translocation, a chimeric gene
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encoding the FG-repeat domain of NUP98, which binds the histone acetyltransferase CBP/p300,
fused to the carboxy-terminal 60% of NSD1, which contains the exons 6-23 that include almost all
the functional domains of NSD1 (Wang et al. 2007). According to the mechanism proposed, NSD1
has H3K36 methyltransfesare activity and it regulates normal Hox gene expression, consequently
deregulated  NUP98–NSD1  activity  could  link  persistent  methylation  of  H3K36  to  enforced
expression of HoxA genes in AML. 
NUP98-NSD1 binds to the Hox-A locus, where it exerts two “writer” activities on histones, i.e.
H3K36 methyltransferase and acetylation,  mediated by NSD1 SET domain and by the NUP98-
recruited CBP/p300, respectively. The combination of these epigenetic marks excluded the H3K27
trimethylation of the locus mediated by EZH2 that it is able to silence the  Hox-A locus.  In this way
only six genes,  HoxA5, HoxA7, HoxA9, HoxA10, Meis1 and Rab38, were up-regulated fivefold or
more in NUP98–NSD1 progenitors, demonstrating a high targeting specificity by NUP98–NSD1 on
the Hox-A locus and on Meis1. NUP98–NSD1 enforces self-renewal and arrests differentiation by
activating  transcription  of  Hox-A  genes  and  Meis1.  The  gene  up-regulation  coincides  with
appearance of the H3K4me3 active mark and the depletion in of H3K9me3 repressive mark. Both
acetylation and H3K36 methylation were shown to be essential for the disease: the ablation methyl
and acetyl tranferase activity prevented the immortalization of the progenitors (Wang et al. 2007).
Importantly, the two PHD finger in C-terminal region of NSD1 are important for the binding with
the  DNA probes 5’ of the  Hox-A locus. The deletion mutant lacking these two modules was not
associated with Hox-A gene actication and  stem cell immortalization. Thus, the chromatin binding
activity of these domains is crucial for the leukaemogenesis by the chimaeric protein NUP98/NSD1
and According to the proposed model, the recruitment of the NUP98/NSD1 on specific promoter
regions is mediated by an unknown adaptor (Wang et al. 2007). 
The second pathology in which NSD1 is involved is the Sotos syndrome, an overgrowth disorder.
Sotos syndrome is a human developmental and cognitive disorder  due to heterozygous mutations in
NSD1 (Tatton-Brown et  al.  2005;  Tatton-Brown and Rahman 2007).  This  syndrome is  a  rare
genetic  disorder  (its  incidence  is  approximately  1  in  14,000 births)  characterized  by  excessive
physical  growth  during  the  first  2  to  3  years  of  life.  The  disorder  is  associated  with  mental
retardation, delayed motor, cognitive, and social development, hypotonia (low muscle tone), and
speech impairments. Children with Sotos syndrome tend to be large at birth and are often taller,
heavier, and have larger skulls and larger heads (macrocephaly) as compared to healthy children in
their age. Although most cases of Sotos syndrome occur sporadically, familial cases have also been
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reported.  Point mutations, deletions that involve  9 of 13 NSD1 domains, including all 6 PHD
domains, cause the Sotos syndrome, indicating that each NSD1 domain performs an essential role
(Pasillas, Shah, e Kamps 2011). Sotos syndrome point mutations found in NSD1 PHD fingers are
listed in Table 2. Interestingly,  numerous mutations associated with Sotos syndrome lie in NSD1-
PHD5 and NSD1-C5HCH  PHD finger domains.
Domain Mutation(s)
PHD1 C1570F (2)
PHD2 C1596R (7); C1611S (2);  H1616L (3); C1619R(2); L1637P(3)
PHD3 C1640Y (2); R1663C (2); C1674W (3) I1687N  (4); P1690L (7)
PHD4 C1713G (7); P1726L (4); A1727P (1) C1733R (7) C1733S (7) L1734P (7)
 PHD5 C2124R (2); Y2142N (2); H2143E (3); H2143Y (2) H2143Q (2); C2146R (2); R2152Q (6); C2159Y
(2); H2162R (2)
C5HCH C2164R (2); C2164Y (2); C2167R (1); C2178R (2); F2182I (2); C2183S (2);H2205R (2); C2178Y (7)
SETdomain R1952W (2); G1955D (2); G1955R (2); R1984Q (1); Y1997C (2); Y1997S (2); R2005Q (2); R2017Q
(2); R2017W (2); C2027R (7); G2041D (3)
PWWP2 C1773R (2); C1773S (4); G1792V (2); V1796F (7)
Table 2. Sotos syndrome point mutations in NSD1. References are: 1: Kurotaki et al., 2003; 2: Tatton-Brown et al., 2005; 3:
Douglas et al., 2003; 4: Rio et al., 2003; 5: Turkmen et al., 2003; 6: Melchior et al., 2005; 7: Pasillas et al., 2011.
Patients  with  identical  mutations  are  characterized  by  extreme variability  in  terms  of  learning
disability and clinical features, possibly due to phenomena such as stochastic factors and functional
polymorphisms of NSD1-interacting genes (Tatton-Brown et al. 2005). Visser R et al studied the
gene expression profile of dermal  fibroblasts from Sotos syndrome patients suggesting that the
haploinsufficiency  of  NSD1  is  associated  with  the  deregulation  of  the  MAPK/ERK  signaling
pathway, involved in cell differentiation. However, the molecular basis of NSD1 function in Sotos
syndrome pathogenesis is still unknown (Visser R et al. 2012). 
Rahman  et  al 2003  noted  an  increased  incidence  of  neural  crest  tumors  in  Sotos  cases  with
confirmed NSD1 aberrations (Rahman N et al. 2005). The hypermethylation of CpG island at the
NSD1  promoter  leads  to  inactivation  of  NSD1  in  neuroblastoma  (LAI-5S  and  LAN-I)  and
glioblastoma (U373-MG) cells lines. In these cell lines, the minimal expression of the NSD1 is
associated with reduced levels of trimethylation at residues H4K20 and H3K36. In particular in
neuroblastoma cell line, when NSD1 is depleted by means of RNA  interference, it is observed an
up-regulation of the oncogene Meis1. The quantitative Chip shows that NSD1 localizes at 5' of
Meis1 promoter  led to   transcriptional  repression of  the  gene  via  its  H4K20 methyltransferase
activity.  Sotos  syndrome lymphoblastoid  cells  ,  which  had  an  NSD1 genetic  defect  (  R604X,
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L779X,  C1640Y,  R2017W,  OGS 55,  OGS368,  OGS661)  expressed   high  levels  of  the  Meis1
transcript if compared with healthy donors (Berdasco M et al. 2009).  The histone modification
profile in tumour cells (LAI-5S) and Sotos syndrome cell line in  5' region of Meis1 is very similar. 
The epigenetic silencing or genetic loss of NSD1 led to an enrichment in active marks (such as
H3K4me3)  and  a  depletion  in  repressive  marks  (H4K20me3,  H3K9me3,  and  H3K27me3).  In
contrast, when the NSD1 CpG island promoter are unmethylated (neuroblastoma cells, SN-N- JD)
the  recruitment  to  5'  region  of  Meis1  is  associated  with  an  enrichment  in  the  transcriptional
silencing histone marks (H4K20me3, H3K9me3, and H3K27me3) and a depletion in the active
marks (H3K4me3). These experimental data suggest that NSD1 is a versatile protein that can act as
a corepressor or coactivator depending on the cellular context (Berdasco M et al. 2009). 
NSD1 forms a complex with the repressor factor Nizp1, this complex is probably responsible for
chromatin compaction and suppression of gene expression. In the next  chapter, I will  describe  the
biological role of Nizp1 and  how it  interacts with NSD1.
1.6 Nizp1 is a zinc finger containing protein that interacts with NSD1
Nizp1 contains 585 amino acids, with a calculated molecular mass of 66.5 kDa (Nielsen et al. 2004)
(Fig 9).  The N-terminal region of Nizp1 (amino acids 36 to 131) contains a SCAN box, or leucine-
rich region (LeR). This motif  functions  as an oligomerization domain mediating self-association or
association with other proteins bearing SCAN domains. A Kruppel-associated box-A (KRAB-A)
subdomain was identified in Nizp1 between amino acid residues 219 and 259 that  has been shown
to act as a potent transcriptional repressor element when it is targeted to DNA. At the C-terminus,
Nizp1 contains four classical zinc fingers (C2H2,  named briefly ZnF), ZnF1 to ZnF4, that occur in
two clusters  and are capable of binding to DNA directly. They are preceded by a degenerate copy
of this domain which has an Arg residue in place of the last His residue, and it is named C2HR
motif. The ZnF domains display DNA and protein interaction properties when they are organized in
repeating units. 
Fig 9. Functional domains contenting in Nizp1. The C2HR domain is reported in the red square
Two-hybrid assays in yeast and mammalian cells and GST-pull down have shown NSD1 and Nizp1
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Nizp1
SCAN Zinc finger domainsKRAB-A
motifs interact with each other. In particular the tandem domain (PHD5-C5HCH) at C-terminus of
NSD1 interacts with the C2HR domain of Nizp1. The other two  members of NSD protein family,
NSD2 and  NSD3 that also contain a PHD5-C5HCH tandem domain, are not able to recognize
Nizp1 (Nielsen et al. 2004). 
The role of the complex NSD1 and Nizp1 in gene repression has been evaluated by gene reporter
assays. In  Cos-1 cells, it was assayed the repressive activity of the Nizp1 C2HR motif alone or in
combination with overexpressed NSD1. In presence of both the protein the  report gene expression
is  strongly  reduced.  Moreover,  an  NSD1  mutant  protein,  NSD1C2073A/  C2076A,  bearing
mutations that abolished the interaction with the C2HR motif, did not affect the expression of the
target gene. This results indicate the interaction between the two protein is fundamental for the gene
repression.  In  a  second  set  of  experiments  the  role  of  full-length  Nizp1  to  mediate  the  gene
repression was evaluated. In HT1080 cells,  in presence of full-length Nizp1 and over-expressed
NSD1 it is possible to observe  the efficient repression of the reporter gene. 
However,  the C2HR mutations preventing NSD1 interaction severely reduced but did not abolish
the  Nizp1  repression  activity.  This  data  suggests  that  also  the   KRAB-A domain  of  Nizp1  is
involved in  gene repression.  This domain has been  shown to silence transcription through the
recruitment of the co-repressor protein TIF1β/KAP-1(Nielsen et al.  2004).  As mentioned above,
NSD1 has an histone methyltranferase (HMTase) domain that specifically methylates histone H3 at
lysine 36 (H3K36) and histone H4 at lysine 20 (H4K20) but the  functional consequences of these
modifications remain to be determined. 
Nielsen  et al 2004 propose a model in which  Nizp1 is a DNA-binding transcriptional repressor
whose  function  is  to  target  the  H3-K36  and  H4-K20  HMTase  activities  of  NSD1  to  specific
promoters. The details of the molecular mechanism that involve the interaction between NSD1 and
Nizp1 are largely unknown. As first step towards the molecular characterization in this study we
focused our attention on C2HR motif of the Nizp1 and on its interaction with NSD1. This module
belongs to the family of ZnF domains in which the final histidine is absent and replaced by arginine
residue. In the next chapter we will describe the biological and structural characteristics of the zinc
finger modules.
1.6.1    The zinc finger modules in protein interaction
The zinc finger domains has been shown to be very abundant in eukaryotes, about the 3% of human
genes  encode  ZnF-containing  proteins  (Bouhouche,  et  al.  2000).  Initially  discovered  in  the
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transcription factor TFIIIA from Xenopus oocytes (J. Miller, et al.1985), the classical ZnF motif
consists  of a short   sequence (30-40 residues) that uses two or three cysteines and two or one
histidines to coordinate a zinc ion (C2H2 or C2HC types, respectively).
 The zinc finger domains fold into a characteristic structure consisting of an α-helix and a β-hairpin
held together by the zinc ion. The coordination geometry of four coordinated zinc atoms is most
commonly tetrahedral (Gamsjaeger et al. 2007) (Fig 10).
Fig 13. Zinc finger domain topology
In the last 20 years since zinc-binding repeats were first identified in a protein, the DNA-binding
properties of zinc-fingers have been explored in exquisite detail (Wolfe SA et al 200), and it is now
possible to generate a specific zinc finger proteins that will target specific genomic sites. These zinc
finger  domains  have  proved  to  be  common  in  complex  organisms:  in  humans,  >15  000  such
domains are predicted to exist in about 1000 different proteins (Rubin GM et al 2000).
It has also emerged that zinc fingers can mediate protein–protein interactions. In the past 3–5 years,
detailed  structural  and  functional  data  have  been  reported  for  several  zinc  finger-protein
interactions,  showing  unequivocally  that  they  can  function  as  protein  recognition  motifs.  In
particular,  it  has  been identified  a  family  of  classical   zinc  finger  domains,  in  which  the  zinc
coordinating histidine is not conserved and residues such as aspartate have been shown to function
as zinc ligands (Andreini et al 2011). Several studies demonstrate that these domains maintain their
protein fold and their ability to recognize DNA promoter region and protein partners (Simpson et al.
2003).
24
Aim of the work
NSD1 is a multitasking protein whit a dual activity that can  act both as a repressor and coactivator,
depending on the  cellular  context  (Berdasco et  al.  2009;  Wang et  al.  2007).  This versatility  is
probably linked to the presence of six PHD finger domains that function as structural hubs for
multiple binding events recognizing both epigenetic markers and non-histone proteins (Sanchez and
Zhou 2011). The emerging standard strategy for characterizing chromatin-binding proteins, such as
NSD1, is to establish the relationship between a discrete portion of the large chromatin-binding
protein, called module or functional unit, and its substrate (Malecek and Ruthenburg 2012). 
In this project we focused our attention on the tandem PHD finger domains in the C-terminal region
of NSD1 that is composed by PHD5 and C5HCH finger domains, briefly named as NSD1-P5C5.
The tandem domain appears to play a multifaceted role working as both histone reader (H3K4me3
and H3K9me3, Pasillas M et al. 2011) and as interaction domain with the C2HR domain of the
transcriptional repressor Nizp1 (Nielsen et al. 2004). The complex formed by NSD1 and Nizp1 is
probably  responsible  for  chromatin  compaction  and  suppression  of  gene  expression.  It  was
speculated  that  the  abrogation  of  NSD1-mediated  repression  of  growth-promoting  genes  might
contribute to pathological conditions (Lucio-Eterovic et al. 2010), such as the Sotos Syndrome an
overgrowth disorder that is due to point pathological mutations in NSD1 domains (Tatton-Brown e
Rahman 2007). In this context, about 20 mutations target the NSD1-P5C5 suggesting that it has a
role in pathology. From the structural point of view,  it  would be informative to study how the
NSD1-P5C5 fold is affected by these mutations.  NSD1-P5C5 is essential for the pathogenesis of
acute  myeloid  leukaemia  (AML) caused by the  chimeric  protein  NUP98/NSD1 that  forces  the
abnormal activation of Hox-A and Meis1 genes. The deletion of these two domains is sufficient to
abolish NUP98/NSD1 interaction with chromatin, preventing both the transcription activation and
the immortalization of myeloid progenitors. 
Until now, no structural data are available about the interaction of NSD1-P5C5 with non-histone
proteins and epigenetic markers. Structural and thermodynamic studies characterizing the molecular
details  of  these  interactions  would  strongly  contribute  to  understand  NSD1  function  in
physiological and pathological conditions and would possibly offer a structural platform to develop
synthetic modulators of these interactions.
In  this  framework,  the  structure  and  dynamic  properties  of  this  tandem  domain  have  been
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characterized by NMR spectroscopy by our group. In this thesis we focused our attention on the
role of NSD1-P5C5 as interactor of Nizp1-C2HR with the aim to study by biophysical techniques
(NMR spectroscopy,  ITC  experiments):  (1)  the  structural  and  functional  effect  of  pathological
mutations in NSD1-P5C5 (2) the structure of Nizp1-C2HR, (3) the interaction of NSD1-P5C5 with
Nipz1-C2HR domain. 
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2. Materials and Methods
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3.1. General molecular biology techniques 
The major molecular biology procedures applied to carry out cloning and site direct-mutagenesis on
the murine Nsd1 fifth PHD finger in association with the C5HCH domain (NSD1-P5C5,spacing
residues  Glu2014-Asp2104,  cod.sequence  Q96L73)  and  murine  Nizp1  first  zinc  finger  domain
(Nizp1-C2HR, spacing residues Glu397-Lys434, cod. sequence Q5SXI5) are described in details in
the following. 
3.1.1 Standard DNA amplification of the genes of interest
NSD1-P5C5 was cloned into NcoI/KpnI sites of pETM11 expression vector (EMBL)
The plasmids for expression in  E.coli  of Nizp1-C2HR domain were generated using a multi-step
PCR-based process. The regions were amplified from the pGEX vector containing the cDNA of the
murine Nizp1 protein. According to the sequence the forward and reverse primers were designed
and synthesized by PRIMM company, Italy. The used oligonucleotides are reported in Table 1 and
the start and the stop codons are bold faced.
Primer
Name 
Sequence Length Restriction
Enzyme
Nizp1_f 5'-GGCGCCATGGAGGTG CAAA CCT CAC-3' 25nt NcoI
Nizp1_r 5'-CAGAAGCCACACAAATAAGCGGCCGCCCG-3' 29nt NotI
Table 1 - Description of the primers used for the cloning procedure of Nizp1-C2HR
The composition of PCR reaction, in a final solution of 50 μL, is reported in Table2  and the PCR
reaction was performed in a thermocycler, according the amplification protocol reported in Table 3.
Reagent Concetration
DNA template 30ng
5' primer 1mM
3' primer 1mM
dNTPs 0.1mM
DNA polimerase 3 units
Nuclease free water until 50 μl
Table 2 - Composition of standard PCR reaction mix
Step Temperature (°C) Time Cycle applied
Inizial Denaturation 95 2' 1
Denaturation 95 45'' 35
Anneling 55 30'' 35
Elongation 72 2' 35
Final Elongation 72 6' 1
Table  3- Standard amplification protocol
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The amplified DNA fragments were purified by means of agarose gel (0.8%), digested for 3 houses
at 37°C with NotI and KpnI (Table 4) and then purified again on agarose gel.
Reagents Concentration or volume 
DNA volume 10-50 ng
NotI 5 units 
KpnI 5 units
Digestion buffer 5 μl
Nuclease free water until 50 μl
Table  4- Composition of standard reaction mix for digestion with restriction enzymes 
Ligation between the DNA fragments and the destination vector pETM-41 (the vector provided by
EMBL was previously digested with NotI-KpnI and purified), was performed for 2 hours at 22°C
(Table 5). 
Reagents Concentration or volume 
DNA vector 10-20 ng
DNA amplified 2-4ng
Ligase T4 enzyme 200 units
Ligase buffer 2 μl
Nuclease free water until 20 μl
Table 5 - Composition of standard ligase reaction mix 
DNA fragments were mixed at 1:5 ratio of vector and inserts, according to the formula: 
ng (digested insert) = 5 x ( ng (digested insert) x length (digested insert) )/ length (digested vector) 
The ligation solutions were transformed in DH5α  E.coli cells,  the constructs were extracted by
miniprep and verified by DNA sequencing. The vector pETM-41 containing the correct sequence of
the insert was used to transform the BL21 (DE3) competent cells for the protein expression. 
3.1.2 Site-directed mutagenesis protocol
The generation of NSD1-P5C5 and Nizp1-C2HR mutations were generated through PCR-based
site-directed mutagenesis. For each mutagenesis two synthetic oligonucleotide primers containing
the desired mutation were purchased by PRIMM (Milan, Italy) and reported in Table 6 and Table 7. 
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Primer
Name 
Sequence Length
Y30N_f 5'-GCCAGGCTGCCCTAAA GTCAAC CATGCAGACTGTCTGAAT C-3' 19nt
Y30N_r 3'-GATTCAGACAGTCTGCATGGTTGACTTTAGGGCAGCCTGGC-5' 21nt
F70I_f 5'-GTGAGATGTGCCCCAGCTCCATTTGCAAGCAACATCGAGAAGG-3' 21nt
F70I_r 3'-CCCTTCTCGATGTTGCTTGCAAATGGAGCTGGGGCACATCTCAC-5' 21nt
R40Q_f 5ʼ-CTATGAAATAGGAAACCGCAAGGCGGCTTTATACTATGGCG-3 20nt
R40Q_r 5ʼ-CGCCATAGTATAAAGCCGCCTTGCGGTTTCCTATTTCATAG-3ʼ 20nt
H30Y_f 5ʼ-CTATGAAATAGGAAACCGCGCTGCGGCTTTATACTATGGC-3ʼ 20nt
H30Y_r 5ʼ-GCCATAGTATAAAGCCGCAGCGCGGTTTCCTATTTCATAG-3ʼ 20nt
H30R_f 5ʼ-CTATGAAATAGGAAACCGCTATGCGGCTTTATACTATGG-3ʼ 20nt
H30R_r 5ʼ-CCATAGTATAAAGCCGCATAGCGGTTTCCTATTTCATAG-3ʼ 20nt
H50R_f 5'-G AAG TGG GAA TGT CCT TGG CGC CAG TGT GACGTGTGTGGG-3' 21nt
H50R_r 3'-CCCACACACGTCACACTGGCGCCAAGGACATTCCCACTTC-5' 19nt
H93R_f 5'-GCG TCTGTCTTGTACTGAACGGGATTAAGGTACCGGATCC G-3' 19nt
H93R_r 3'-CGGATCCGGTACCTTAATCCCGTTCAGTACAAGACAGAC-5' 19nt
Table 6 - Description of the primers used for site-directed mutagenesis for NSD1-P5C5
Primer
Name 
Sequence Length
R34A_f 5'-GG CAC CTG CGC AGC GCC AGG GAG CAG AAG CCA C-3' 14nt
R34A_r 3'-GTGGCTTCTGCTCCCTGGCGCTGCGCAGGTGCC-5' 16nt
Table 7- Description of the primers used for site-directed mutagenesis for Nizp1-C2HR
Mutagenesis reactions were set up for each mutants , as indicated in Table 8
Reagent Concentration
DNA template 20-50ng
5' primer 1mM
3' primer 1mM
dNTPs 0.2mM
DNA polimerase 3 units
Nuclease free water until 50 μl
Table 8 - Composition of standard PCR reaction mix
PCR amplification reactions were performed following the protocol reported in Table 9.
Step Temperature (°C) Time Cycle applied
Inizial Denaturation 95 2' 1
Denaturation 95 45'' 25
Anneling 55-60 30'' 25
Elongation 72  for  2  minutes/kb  of
plasmide
2' 25
Table 9- Standard amplification protocol
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When the reaction was complete, 10 U of the Dpn I (Promega) restriction enzyme were added
directly to each amplification, each reaction was incubated at 37 ｰ C for one hour and at 70 ｰ C for
25  minutes.  DH5α  E.coli cells  were  transformed  using  50  μL of  each  reaction  solution.  The
sequences of the mutants were verified by sequencing finally the correct plasmids were used to
transform BL21-(DE3) competent cells to carry out protein expression.
3.2. Expression of recombinant protein in E. coli
In the following session are described the protocols used for the hetorologous expression of the
recombinant protein. The expression of unlabelled recombinant protein was carried out in LB reach
media. NMR experiments required 15N- and 15N-13C- isotopic labeling. Expression of labeled protein
samples was achieved by growing and inducing BL21(DE3)  E. coli cells  in  15N or  15N-13C M9
minimal medium (see Table 10 for recipes) instead of LB medium. In M9 minimal medium, 15N-
HCl and 13C-glucose are, respectively, the unique source of nitrogen and carbon during the bacterial
growth  and  induction,  so  that  we  can  achieve  uniformly  15N-  or  15N-13C-labeled  recombinant
proteins. 
M9 minimal medium (1L) for
15N-labeling
M9 minimal medium (1L) for
13C-15N-labeling
M9 salts pH 7 10X (100 ml) Trace Elements 1000X (250
ml)
100 ml M9 salts pH 7 10X 100 ml M9 salts pH 7 10X 10 g Na2HPO4 12.5 g EDTA pH 7.5
1 ml Trace Elements 1000X 1 ml Trace Elements 1000X 3 g KH2PO4 2.10 g FeCl3•6H2O
4 g D-glucose 4 g 13C-D-glucose 0.5 g NaCl 210 mg ZnCl2
1 ml MgSO4 1M 1 ml MgSO4 1M 30 mg CuCl2•2H2O
0.3 ml CaCl2 1M 0.3 ml CaCl2 1M 25 mg CoCl2•6H2O
3 g 15NH4Cl 3 g 15NH4Cl 25 mg H3BO3
1 ml kanamycin 25 mg/ml 1 ml kanamycin 25 mg/ml 4 mg MnCl2•6H2O
1 ml thiamin 1 mg/ml
1 ml biotin 1 mg/ml
Table 10 . Recipes of M9 minimal medium for uniformly 15N- and 13C-labeling
3.2.1 NSD1-P5C5 expression protocol
BL21(DE3)  competent  cells  transformed with  pETM-11-P5C5 vector  were  grown in  1L reach
media (LB) or minimal media (added of 0.2mM of ZnCl2) at 37°C for about 2-3 hours. The protein
expression was inducted with 1mM of IPTG (isopropyl  β-D-1-thiogalactopyranoside)  when the
OD600 = 0.8-1 and performed for about 20 hours. The domain is expressed with a N-terminal tag of
six histidines (6-His tag). 
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The cellular pellet was re-suspended in 15 ml of 20 mM TRIS-HCl pH 8, containing 150 mM NaCl,
0,2% NP-40, 1 mM TCEP, 0.1mM of ZnCl2 , 20 μg /ml DNAseI, 20 μg/ ml RNAse I and 50 μg/ml
lysozime. Cells were disrupted by sonication. Cell debris was separated from the supernatant by
centrifugation at  15.000 g for  30 minutes  at  4°C.  Heterologous expression  of  the  NSD1-P5C5
mutants were carried out using the same protocol described for the wild-type protein.
3.2.2 Nizp1-C2HR expression protocol
Large-scale expression of the recombinant Nizp1-C2HR domain was achieved in 1 l batches of LB
medium, starting from a pre-inocule of 20 ml of a 16 hours cell culture. Cells were grown at 37°C,
until the OD600 reached 0.8 - 1. Expression was induced by addition of IPTG at final concentration
of 1 mM and the temperature was decreased to 28°C after induction. The domain is expressed with
a N-terminal tag of six histidines (6-His tag)  followed by the MBP protein. Cells were harvested
about 16-20 hours after induction by centrifugation at 8.000 g for 30 minutes at 4 °C. The cellular
pellet was re-suspended in 15 ml of 20 mM TRIS-HCl pH 8, containing 150 mM NaCl, 0,2% NP-
40, 1 mM TCEP, 0.1mM of ZnCl2 , 20 μg /ml DNAseI, 20 μg/ ml RNAse I and 50 μg/ml lysozime.
Cells were disrupted by sonication. Cell debris was separated from the supernatant by centrifugation
at  15.000 g for  30 minutes  at  4°C.  Heterologous  expression of  the  NSD1-P5C5 mutants  were
carried out using the same protocol described for the wild-type protein.
3.3. Purification of recombinant proteins in E. coli
The protocol for purification of recombinant proteins will be describe in this chapter. 
3.3.1 NSD1-P5C5 purification protocol
The recombinant His(6)tagged NSD1-P5C5 was purified by affinity chromatography. 
The protein in the soluble fraction was loaded onto a column containing 5 ml of the Ni-NTA affinity
resin (Qiagen) pre-equilibrated with 25ml of the same buffer used for the bacteria lysis, and then
washed with 10CV of the buffer. 20 mM TRIS-HCl pH 8, containing 150 mM NaCl, 2 mM of 2-β-
mercaptoethanol, 0.1mM of ZnCl2 , 10 mM of imidazole and with 5 CV of buffer 20 mM TRIS-
HCl  pH  8,  150  mM  NaCl,  2  mM  of  2-β-mercaptoethanol  0.1mM  of  ZnCl2 and  20  mM  of
imidazole. The recombinant protein was eluted in the buffer of 20 mM TRIS-HCl pH 8, 150 mM
NaCl, 2 mM of 2-β-mercaptoethanol 0.1mM of ZnCl2 and 500 mM of imidazole. The His(6)tag
was removed by TEV digestion and the protein solution was dialysed over night against the buffer
20 mM TRIS-HCl pH 8, 150 mM NaCl, 2 mM of 2-β-mercaptoethanol 0.1mM of ZnCl2 .
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The protein in insoluble fraction was re-suspend in the buffer 20 mM TRIS-HCl pH 8, 150 mM
NaCl, 2 mM of 2-β-mercaptoethanol and 6 M urea. After about 30 minutes of incubation at 37°C in
agitation the protein solution was centrifuged at 15.000 g for 30 minutes at 4°C. The supernatant
obtained was loaded onto a column containing 5 ml of the  Ni-NTA  affinity resin (Qiagen) pre-
equilibrated with 25ml of the same buffer. The resin was washed two times with 10 CV of the same
buffer with increasing amount of imidazole (10mM and 20mM, respectively). The elution was carry
out with the buffer 20 mM TRIS-HCl pH 8, 150 mM NaCl, 2 mM of 2-β-mercaptoethanol 0.1mM
of ZnCl2 and 500 mM of imidazole. In order to refold the protein domain after the elution the
protein solution was dialysed over night at 4°C against the buffer 20 mM TRIS-HCl pH 8, 150 mM
NaCl, 5 mM of 2-β-mercaptoethanol 0.2mM of ZnCl2 . The refolded protein was digested with
TEV protease. The digested protein solution was loaded onto a 3 ml Ni2+-NTA column (previously
equilibrated  with  the  dialysis  buffer)  to  remove 6His-tags  and TEV protease  (it  also has  a  N-
terminal  6His-tag).  The  flow-through,  containing  only  the  recombinant  protein,  was  collected,
concentrated and loaded onto a Superdex 75 size exclusion chromatography column (GE Healthcare
Life Science) for the latest purification step. The fraction containing NSD1-P5C5 were combined
and concentrated using Vivaspin (Sartorius) tubes with a 2 kDa cut-off. Protein purity, as well as the
completion of proteolytic digestion, were checked by SDS-PAGE in each purification step. 
3.3.2 Nizp1-C2HR purification protocol
His(6)MBP-tagged Nizp1-C2HR was purified using standard Ni-affinity chromatography protocol. 
The soluble fraction obtained by cell lysis was loaded onto a column containing 5 ml of the Ni-NTA
pre-equilibrated with 25 ml of the same buffer used to re-suspend the cellular pellet and incubate for
30 minutes at 4°C in agitation. The column was washed with 10 CV of the buffer 20 mM TRIS-HCl
pH 8,  containing  150  mM  NaCl,  2  mM of  β-mercaptoethanol  0.1mM  of  ZnCl2 ,  10  mM  of
imidazole  and  with  5  CV  of  buffer  20  mM  TRIS-HCl  pH  8,  150  mM  NaCl,  2  mM  of  β-
mercaptoethanol 0.1mM of ZnCl2 and 20 mM of imidazole. The recombinant protein was eluted in
the buffer of 20 mM 20 mM TRIS-HCl pH 8, 150 mM NaCl, 2 mM of 2-β-mercaptoethanol 0.1mM
of ZnCl2 and 500 mM of imidazole. Immediately, after elution the protein solution was added with
TEV protease (about  1 mg of TEV for 30 mg of recombinant  protein) in  order to remove the
His(6)MBP-tag. The protein solution was dialyzed over night against the buffer 20 mM TRIS-HCl
pH 8, 150 mM NaCl, 2 mM of 2-β-mercaptoethanol 0.1mM of ZnCl2 . 
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The dialysed protein solution was loaded onto a 3 ml Ni2+-NTA column and the flow-through,
containing only the recombinant protein, was collected, concentrated and loaded onto a HiLoad
16/60 Superdex sixe exclusion chromatography column (GE Healthcare Life Science). The fraction
containing Nizp1-C2HR were combined and concentrated using Vivaspin (Sartorius) tubes with a 2
kDa cut-off.
3.4. Nizp1-C2HR synthetic peptides.
Synthetic  peptides  corresponding  to  Nizp1-C2HR  domain  have  been  purchased  from  CASLO
Laboratory (Lyngby, Denmark) as lyophilized acetate salts. They were used for NMR experiments
and they were amidated at N-terminus and acetylated at C-terminus. Their purity were  certificated
of 98-99% (see Table 11 for the list of the synthetic peptides).
Peptide name Sequence Lenght 
Nizp1-C2HR KSYVCPNCGKIFRWRVNFIRHLRSRRE 27 residues 
Nizp1-C2HR_RH KSYVCPNCGKIFRWRVNFIRHLRSHRE 27 residues 
Nizp1-C2HR_NA KSYVCPACGKIFRWRVNFIRHLRSHRE 27 residues 
Table 11.  Nizp1-C2HR synthetic peptides used in binding assays
3.5. Isothermal Titration Calorimetry (ITC)
Isothermal Titration Calorimetry (ITC) is the only technique that can simultaneously determine all
binding parameters in a single experiment. The methodology allows determination of the binding
affinity (Ka),  stoichiometry, enthalpy of the reaction in solution, without the need to use labels.
Using the equations 1 and 2 the values of the dissociation constant (Kd, μM), the Gibbs energy (ΔG,
kJ mol-1) and the entropy (ΔS, kJ K-1) can be deduced. 
Ka = 1/Kd, [Eq.1]
ΔG = ΔH -TΔS, [Eq.2]
In  the  instrument  there  are  two  cells,  made  of  a  highly  efficient  thermal  conducting  material,
typically gold. Each cell is equipped with a heater. A protecting adiabatic jacket avoids thermal
exchange with the outside. The temperature of both cells is measured simultaneously.  
One of the cell is filled with buffer and used as a reference cell. Its heater applies a constant power
to  maintain  the   temperature  stable  along the  experiment.  The other  cells  contains  the  sample
dissolved in the same buffer, and its heater initially applies the same power.  The ligand is loaded
into a syringe which sits in a very accurate injection device. The injection device is inserted into the
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sample cell containing the protein of interest. 
A series of small aliquots of ligand are injected into the protein solution. If there is a binding of the
ligand to the protein, heat changes are detected and measured.  If the reaction is exothermic, the
temperature of the cell increases and its heater reduces the applied power to compensate that with
respect to the reference cell. If the reaction is endothermic, the opposite occurs. The instruments
records  the applied power over time ( μJ sec-1). At each ligand injection the recorded power reaches
a maximum (or a minimum) value and afterwards its initial value is restored, defining a peak. With
the  consecutive  ligand injections,  the  number  of  available  protein binding site  is  progressively
decreased which is reflected by a progressive decrease of the released (or absorbed) thermal energy.
Eventually the protein sample becomes saturated and the peaks display a constant size reflecting the
ligand heat dilution see (Fig. 1).  
Fig.  1  Representative  diagram  of  a  typical  power  compensation
ITC. Major features of this type of instrument such as the reference
and sample cells, syringe for adding titrant, and the adiabatic shield
are noted in the figure. This diagram shows an oversimplification of
how  the  power  applied  by  the  instrument  to  maintain  constant
temperature  between the  reference and sample cells  is  measured
resulting in the instrument signal.
The areas under each peaks are integrated yielding the total exchange heat per injection (kcal per
mol of injectant), and data plotted in function of the ligand/protein molar ration at each inijection
point.  A mathematical   model is  fitted to  the experimental  data.  For the proteins  with a single
binding site, a sigmoidal curve is fitted (see Fig. 2). The slope at the liner fraction of the curve given
the Ka value. The molar ratio at which the interaction is 50%  saturated gives the stoichiometry (n).
the difference between the initial and the final total exchange heat gives the enthalpy (ΔH) of the
reaction (see Fig. 2). 
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Fig. 2: Data interpretation. Heat peaks after each legand injection are
integrated and a curve is fitted to the data. Several thermodynamic
parameters  can  be  deduced  as  well  as  stoichiometry  of  the
interaction.  
We used ITC to test the binding of Nizp1-C2HR domain to NSD1-P5C5. 
ITC  titration  was  performed  using  a  VP-ITC  isothermal  titration  calorimeter  (MicroCal  LLC,
Northampton,  MA,  USA).  During  the  night  before  titration,  recombinant  protein  and synthetic
peptide were dialyzed against the same buffer, containing 20 mM NaH2PO4/Na2HPO4 pH 7.2, 150
mM NaCl, 2 mM 2-β-mercaptoethanol and 100 μM ZnCl2. Titration was carried out at 23°C by
injecting step by step a  0.2 mM Nizp1-C2HR protein solution into a 15  μM NSD1-P5C5. The
titration parameters were stirring of 307 rpm, 28  injections of 10 μl each and 15 minutes of spacing
between injections into the ITC sample cell of 1.41 ml. Control experiments were performed under
identical conditions to determine the dilution heat of the titrant protein  into buffer. The final data
were  analyzed  using  the  software  ORIGIN  7.0  (OriginLab  Corp.,  Northampton,  MA,  USA),
integrals of differential heats of injection were corrected by dilution heats and finally fitted by the
proper binding model and nonlinear least-square regression.
3.6. NMR spectroscopy of biomolecules
In these  section the basic theoretical and practical concept  behind the NMR experiments that are
the basis of the results presented in this thesis are summarized. 
3.6.1 Basic NMR characterization of a protein: 1D and HSQC
The acquisition of a 1H 1D experiment is usually the first step in the characterization of a protein
sample.  This  experiment  does  not  require  the  isotopic  enrichment  of  the  sample  an  gives
information on the protein fold and stability. In a folded protein proteins sample a large variety of
well-defined chemical environments, so signals in the spectrum are dispersed in a wide range of
frequencies ranging from 11 to almost 0 ppm. Unfolded proteins yield  1D spectra with much lower
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signal dispersion (see Fig. 3). 
Fig. 3: Example of 1H 1D NMR spectrum. In the left and right panel are reported the typical spectra of folded and unfolded protein,
respectively. 
Isotopic enrichment  of the protein with  15N allows the  acquisition of the  HSQC (heteronuclear
single  quantum  coherence)  experiential.  This  is  a  2D  experiment  and  the  magnetization  is
transferred from hydrogen to attached 15N nuclei via the J-coupling. The chemical shift is evolved
on the nitrogen and the magnetisation is then transferred back to the hydrogen for detection.  This is
the most standard experiment and shows all H-N correlations. Mainly these are the backbone amide
groups, but Trp side-chain Nε-Hε groups and Asn/Gln side-chain Nδ-Hδ2/Nε-Hε2 groups are also
visible. Consequently, each peaks is considered to roughly represent the chemical environment of
each amino acid in the sequence. The HSQC spectrum of a folded protein displays a well-dispersed
sharped signals in the 6-11 ppm range in the 1H dimension and in the 140-105 ppm range in the 15N
dimension. In Fig. 4 as example the   1H 15N HSQC NMR spectrum of human ubiquitin .
Fig. 4:  1H 15N HSQC NMR spectrum of human ubiquitin.
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3.6.2 1H-15N NMR titrations and chemical shift mapping
NMR chemical-shift mapping method is a highly sensitive tool to prove binding and to map binding
sites in protein-ligand interactions (Rajagopal et al., 1997). It requires 15N-labeled protein in order to
record 2D 1H-15N HSQC spectra.  Titration begins with the recording of a 1H-15N-HSQC spectrum
of the free protein, then stepwise additions of the unlabelled titrant are performed and followed by
collecting  1H-15N HSQC spectra  after  each  addition.  Ligand  binding  will  cause  change  in  the
electronic environment  of  residues  directly  involved in  the  interaction and also those suffering
structural  rearrangement.  These  changes  will  be  reflected  in  the  spectra  as  chemical-shift
displacements  (CSDs).  The  nature  of  these  perturbations  depends  on  the  exchange  rate  (kex)
between the complex (kon) and the free protein (kof) [Eq.3]: 
 kex =  kon + kof [Eq.3]
Three main exchange regime  can be  distinguished depending on the  relative value  of  kex with
respect to the difference of the resonating frequencies in the bound and the free states (Δω):
• Fast exchange: kex >> Δω. This is the case of interaction that exits only during a fraction of
the  acquisition  time.  The  observed chemical  shift  at  each  titration  point   is  due  to  the
weighted average between the concentrations of the free and bound protein forms, thus it is
proportional to the binding KD (dissociation constant). Displacement will have a maximum
when protein saturation is reached (see Fig. 5). 
• slow exchange regime:  kex <<  Δω . In this case, residues affected  show reduction of their
peak intensities, while new peaks, belonging to the protein in the bound form, appear at
different chemical shifts, with an increasing intensity upon ligand addition (see Fig. 5). 
• intermediate  exchange  regime:  kex ~ Δω.  In  this  situation residues  affected  show
enlargement  of  their  peaks during  titration,  since  it  is  out  of  the  instrument  resolution
distinguishing between peaks belonging to the free and bound protein forms. 
Fig. 5. The dependence of two-dimensional NMR peak shape on exchange rate. (Left)
Fast exchange: peaks move smoothly from free (blue) to bound (red). In the limit of very
fast exchange, peaks have the same shape throughout. As they move out of this limit,
peaks  may  become  broader  when  in  equilibrium  between  free  and  bound,  and  then
sharpen  up  again  close  to  saturation.  (Right)  Slow  exchange:  the  free  peak  (blue)
decreases in intensity as the bound peak (red) increases. (Adopted from Williamson PM,
2013)
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The HSQC titration experiments has been extensively used in this thesis to characterised binding. In
a  typically  experiment,  a  samples  of  the  titrant  species  (4-5  mM) and 0.130  mM  15N-labeled
recombinant protein were prepared in the same buffer (20 mM NaH2PO4/Na2HPO4 pH 6.3, 150 mM
NaCl, 2 mM DTT, 100 μM ZnCl2, 5% (v/v) D2O). Titrations were performed at 298K and for each
point we registered 1D 1H and 2D 1H-15N-HSQC spectra on a Bruker 600MHz NMR spectrometer
equipped with triple resonance cryoprobe and pulse field gradients. 
Spectra were processed with Topspin software  and analyzed with CCPNmr software looking for
changes in chemical shifts. When binding was observed for each residue we were able to measure
the 1H-15N chemical shift displacement (CSD) as:
[Eq.4]
where, for each peak, Δδ is the difference of the chemical shift values between the 1H-15N-HSQC
spectrum of  the  free  protein  and  the  1H-15N-HSQC spectrum of  each  titration  point.  Residues
affected by binding were supposed to be those showing a CSD larger than the average plus one
standard deviation, and they were mapped on the three-dimensional protein structure in order to
display the interaction surface.
3.6.3 Backbone assignment
The interpretation of the HSQC titrations experiment required the assignment of each resonance in
the spectrum to a particular residue in the protein sequence. This is usually archived using a 3D pair
of  the  type  of   HNCα/  CβCα(CO)NH  that  allows  the  assignment  of  backbone  15N  and  15C
resonances.  
In the following I will briefly describe the 3D NMR experiments used for backbone assignment. 
In the HNCα experiment,  the magnetisation is transferred from 1H to 15N and then via the N-Cα J-
coupling to the 13Cα and then back again to 15N and 1H hydrogen for detection. The chemical shift is
evolved for 1HN as well as the 15NH and 13Cα (see Fig. 6). Since the amide nitrogen is coupled both
to the Cα(i) of its own residue and that of the preceding residue Cα(i-1), both these transfers occur
and peaks for both Cα are visible in the spectrum. However, the coupling to the directly bonded Cα
is stronger and thus these peaks will  appear with greater intensity in the spectra. The spectrum
produced  has 3 dimensions: a proton axis (x), a 15N axis (z) and a 13C axis (y). Each strip is
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extracted from the 3D spectrum at a specific nitrogen frequency and at  the  1H frequency of its
amide proton. The sequential assignment is made by matching the alpha carbon chemical shifts of
the residues (i) and (i-1), (see Figure 6). 
Fig. 6:  HNCα experiment. On the left the schematic representation of the magnetization transfers between backbone nuclei, the
arrow indicates the magnetization transfer. On the right an example of NH strip: two Cα peaks should be visible, the stronger one
belongs to the same residue (Cα(i)) and the weaker one belongs to the preceding residue (Cα(i-1)).
The HNCα experiment is coupled to the CβCα(CO)NH experiment.
 In these case the  magnetisation is transferred from 1Hα and 1Hβ to 13Cα and 13Cβ, respectively, and
then from 13Cβ to  13Cα. From here it is transferred first to  13CO, then to  15NH and then to  1HN for
detection. The chemical shift is evolved simultaneously on  13Cα and 13Cβ, so these appear in one
dimension.  The  chemical  shifts  evolved  in  the  other  two  dimensions  are  15NH  and  1HN.  The
chemical shift is not evolved on 13CO (see Fig 7). In this experiment the NH group of each amino
acid is  coupled to the Cα and Cβ of the preceding residue in the protein sequence (named Cα(i-1)
and Cβ(i-1),  respectively).  The sequential  assignment  is  made by matching the  alpha  and beta
carbon chemical shifts (see Figure 7). 
Fig. 7:  CβCα(CO)NH On the left the schematic representation of the magnetization transfers between backbone nuclei, the  arrow
indicates the magnetization transfer. On the right an example of NH strip. Each strip contains two peaks: the  Cα and the Cβ of the
reside preceding the NH group  (named Cα(i-1) and Cβ(i-1), respectively).
The  Cα  and  Cβ chemical shift are strongly depending on the amino acid type. The most common
values  for  each  amino  acid  type  are  extensively  characterized,  and  they  are  used  to  identity
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particular  sequence segments and math then to strip sequences. Therefore a particular  1H-  15N
resonance in the HSQC spectrum can be assigned to a particular residue in the protein sequence 
The HNCα and CβCα(CO)NH was performed using a sample of  13C -15N  NSD1-P5C5 bound to
unlabelled Nizp1-C2HR (ratio 1:1) and a  sample of  13C -15N Nizp1-C2HR bound to unlabelled
NSD1-P5C5 (ratio 1:1) at the final concentration of 0.6-0.7mM in buffer phosphate at pH 6.3, with
150mM NaCl and 2 mM of β-mercaptoethanol. 
3.7. Protein Structure determination
The  determination  of  a  protein  structure  by  NMR  is  based  on  distance  restrains  that  place  a
particular atom in a defined position of the three-dimensional space relative to all other atoms in the
molecule.  In  oder  to  observe  these  restraints,  in  a  typically  experiment,  the  magnetization  is
transferred thought  the space in a phenomenon known as dipolar coupling.  The transfer occurs
between nuclei that are spatially close (< 5 Å) and it produces a measurable signals, called Nuclear
Overhauser Effect (NOE). The NOE intensity is inversely proportional to the sixth power of the
distance between these nuclei, so it can be used as measurement of this distance. 
To determine the 3D structure of the protein by NMR, NOE  distance restrains between the protones
in  the  protein  are  observed  using  NOESY  (NOE  Spectroscopy)  experiments.  In  the
multidimensional NOESY experiments, the NOE effect gives raise to the correlation signals whose
integration is a direct measurement of the inter-atomic distance. Homonuclear 2D  1H -  1H  and
heteronuclear  3D   15N- NOESY spectra  are  used to  acquire  these restrains.  Many intra-residue
signals  are usually observed, as well as signals with residues close in the sequence and in the space
(see Fig. 8).  
NOESY spectra  are  usually  very  crowed  with  signals  and individual  amino  acids  and hard  to
identify, as intra and inter-residue signals are mixed. To help with the assignment, TOCSY (Total
Correlation Spectroscopy) experiments are acquired. In this experiment the magnetisation is transfer
through the bound between nuclei connected by a limited number of covalent bonds.  The coupling
between two particular nuclei is described by field-independet coupling constant J (Hz) that is much
smaller than the chemical shift.  The spectrum displays the correlation peaks between all the atoms
in a spin system.  Each amino acid's said chain has a characteristic spin system, therefore all the
nuclei corresponding to a single residue can be identified and assigned (see Fig. 8). 
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Fig. 8:  Example of TOCSY and NOESY spectra. On the left the general chemical formula of a tripeptide is shown, while on the right
there are part of TOCY and NOESY spectra. In the 2D 1H - 1H TOCSY  the peaks on the diagonal are the NH group of the  amino
acids that are correlated with the nuclei in the own spin system (blue circles). In the 2D  1H - 1H  NOESY  there are both intra-residue
correlations (blue circles), as well as inter-residue correlations (red circles), which allows us to find which residue is next to which in
the peptide chain. 
3.7.1 Resonances assignment
NMR samples contained typically 0.8 mM of unlabeled Nizp1-C2HR  in 150 mM NaCl, 20 mM
KH2PO4/K2HP04 (pH 6.3) and 50 mM ZnCl2. All NMR experiments were performed at 208C on
Bruker Avance 600 Ultra Shield TM Plus 600 MHz spectrometersequipped with triple resonance
cryoprobes and pulsed field gradients. Spectra were processed with Topspin and and analysed with
CCPNMR  (Vranken  et  al  2005).  We  acquired  1H-1H  TOCSY  experiments  for  spin  systems
identification and  1H-1H NOESY 2D spectra acquired in H20 and in D20,  15N-HSQC NOESY to
collect NOEs  that were assigned manually.
3.7.2 Determination of the tautomeric form of histidines
NMR spectroscopy is used to the study of the histidine protonation state of the His residues of
Nizp1-C2HR domain.  15N NMR spectroscopy  has  been used  extensively  to  study the  histidine
imidazole ring, as nitrogen assumes a typical chemical shift value according to the protonation state
of the NH group (Figure 1, Pelton et al, 1993). By combining 15N chemical shifts and J-couplings of
the imidazole ring it is possible to construct the cross-peak patterns expected in a  1H-15N-HSQC
spectrum for histidine in the three different protonation states (Figure 1, Pelton et al, 1993).
Figure  9.  Correlation  schemes  according  to  the  imidazole  protonation  states.  α,  α+ and  β
indicate  the chemical  shifts  of  the protonated  sp3,  protonated sp2 and non protonated sp2
nitrogen, respectively. Taken from Pelton et al., 1993.
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For the Nδ1-H tautomer (Figure 9) two strong correlations (Nε2-Hε1 and Nε2-Hδ2) at nitrogen
chemical shift near 250 ppm and a weaker Nδ1-Hε1 correlation at nitrogen chemical shift around
168 ppm are expected. In addition a very weak Nδ1-Hδ2 correlation peak could be visible.
For the Nε2-H tautomer (Figure 9) the pattern is inverted. A single strong Nδ1-Hε1 correlation at
nitrogen chemical shift near 250 ppm and slightly weaker Nε2-Hε1 and Nε2-Hδ2 correlations at ni-
trogen chemical shift near 168 ppm are expected.
The correlation pattern for protonated, cationic histidines (Figure 9) is very different, therefore it is
easy to identify. Because the chemical shifts of Nδ1 and Nε2 are nearly the same, four correlations
peaks (Nε2-Hε1, Nε2-Hδ2, Nδ1-Hε1 and Nδ1-Hδ2) occur around a nitrogen chemical shift of 176
ppm. 1H-15N long range HSQC experiment was performed on a sample 0.5 mM of 15N-Nizp1-C2HR
in  in 20 mM NaH2PO4/Na2HPO4 pH 6.3, 150 mM NaCl, 2 mM DTT, 50 uM ZnCl2, 10% (v/v)
D2O.    
3.7.3 Structure calculation
Structure of  Nizp1-C2HR was calculated using ARIA2.2 (Rieping et al 2007)  in combination with
CNS (Brunget et al. 1998)  using the experimentally derived restraints (Table 1). All NOEs were
assigned manually and calibrated by ARIA2.2.  The standard procedure to determine the solution
structure  of  a  protein  from  NMR data  is  to  minimize  an  objective  function  that  incorporates
experimental data (intensities of assigned NOE cross-peaks)  and physical knowledge (physical and
chemical  properties  of  the  protein  nuclei  and  chemical  bonds).  A total  of  eight  iterations  (20
structures in the first six iterations) were performed: 200 structures were computed in the last two
iterations. The ARIA2.2 default water refinement was performed on the 20 best structures of the
final iteration. From initial calculations performed without a zinc ion, it was evident that the zinc
coordination site was defined by the two  thiol groups of Cys407, Cys410 and by the Nδ1 atom of
His423. A zinc ion was included in the subsequent and final calculations, assuming a coordination
with tree ligand.
3.8. Crystallization of NSD1-P5C5:Nizp1-C2HR complex
The  determination  of  the  crystal  structure  of  a  biological  macromolecule  requires  the
preparation  of  crystals  suitable  for  x-ray  analysis,  usually  single  crystals  which  are
characterized by a high degree of homogeneity, long-range order and suitable size, with the
optimum being somewhere between 10–4 and 10–3 mm3. Crystallization requires bringing the
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macromolecule to supersaturation.
 The sample should therefore be concentrated to the highest possible concentration without
causing  aggregation  or  precipitation  of  the  macromolecule  (usually  2-50  mg/  mL).
Introducing the sample to precipitating agent can promote the nucleation of protein crystals
in  the  solution,  which  can  result  in  large  three-dimensional  crystals  growing  from the
solution.  There  are  two  main  techniques  to  obtain  crystals:  vapor  diffusion  and  batch
crystallization. In vapor diffusion, a drop containing a mixture of precipitant and protein
solutions is sealed in a chamber with pure precipitant (Figure 10A). 
The batch method relies on bringing the protein directly into the nucleation zone by mixing
protein with the appropriate amount of precipitant (Figure 10B).  In both the methods, the
concentration of the precipitant in the reservoir is higher than in the drop. Due to the concentration
gradient, the water from the drop will evaporate towards the reservoir, thus lowering the volume of
the drop and increasing the protein concentration. At some moment, the concentration of the protein
will  reach  supersaturation,  and  if  all  other  parameters  like  pH,  ionic  strength,  type  of  buffer,
additives, etc. are appropriate, the protein may start to crystallize (Figure 10B, Point B).
Fig 10:The principle of protein crystallization. In a vapor diffusion experiment (A) equal volumes of precipitant and protein are
present in the drop. Water will diffuse out and both the precipitant and protein concentration will be doubled until equilibrium is
achieved between the drop and the reservoir solution. In batch crystallization (B) the precipitant and protein concentration do not
change during the experiment. Point A - Protein stays undersaturated no crystals can be formed, Point B - Protein nucleation occur,
crystals began to form and the concentration of protein in solution drops to saturation. Point C - Protein precipitates, but crystals may
still grow.
3.8.1 Crystallization screening
In order to determine the exact conditions for crystallization, we used the vapor diffusion method
and tested a large number of conditions to find the most optimal combination of all parameters (pH,
ionic strength, type of buffer, additives, etc...). To determine the appropriate sample concentration
for  the  crystallization  screening  we  carry  out  a  pre-crystallization  test  (PCT,  from  Hampton
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Research) which contains fourth conditions: reagent A1 (0.1 M TRIS hydrochloride pH 8.5, 2.0 M
Ammonium  sulfate),   A2  (0.1  M  TRIS  hydrochloride  pH  8.5,  0.2  M  Magnesium  chloride
hexahydrate, 30% w/v Polyethylene glycol 4,000),   reagent B1 (0.1 M TRIS hydrochloride pH 8.5,
1.0  M  Ammonium  sulfateand)  and   reagent  B2  (0.1  M  TRIS  hydrochloride  pH  8.5,  0.2  M
Magnesium  chloride  hexahydrate,  15%  w/v  Polyethylene  glycol  4,000).  Then,  we  used  two
commercial  kits,  to  screen  the crystallization conditions:  Index (96 conditions)  and the Crystal
screen (50 different conditions) both from Hampton Research. 
3.9. HADDOCK web server
The HADDOCK web server was used to calculate the initial structure of the complex formed by
NSD1-P5C5 and Nizp1-C2HR. HADDOCK (High Ambiguity Driven protein-protein DOCKing) is
an  information-driven docking approach for  the modelling of  biomolecular  complexes.  It  is  an
approach that makes use of experimental data, such as the chemical-shift perturbations resulting
from NMR titrations.  The  information  on the  interacting  residues  is  introduced  as  Ambiguous
Interaction  Restraints  (AIRs)  to  drive  the  docking.  The  interacting  residues  are  distinguished
between “active” and “passive” residues. In the case of NMR titration data, the active residues
correspond  to  all  residues  showing  a  significant  chemical  shift  perturbation  upon  complex
formation as well  as a high solvent  accessibility in the free form protein. The passive residues
correspond to the residues that show a less significant chemical shift perturbation and/or that are
surface  neighbours  of  the  active  residues  and  have  a  high  solvent  accessibility.  The  docking
protocol requires the PDB files of the free proteins, and after calculation, the structures are clustered
according to their intermolecular energy, that is sum of electrostatic, van der Waals, desolvation and
AIR energy terms (HADDOCK score). The best cluster was selected on the basis of the lowest
HADDOCK score and Z-score (Dominguez C et al, 2003). 
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4. Results 
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4.0 Introduction 
The recruitment of NSD1 on the chromatin is mediated by Nizp1, through the interaction between
NSD1-P5C5 and Nizp1-C2HR. The complex is probably responsible of the gene silencing. In order
to investigate this mechanism we characterized by biophysical techniques (NMR titrations and ITC
experiments) the binding between the two protein modules involved in the interaction. To perform
this study we solved the structures of both the tandem domain NSD1-P5C5 and of Nizp1-C2HR.
The NMR structure of NSD1-P5C5 was solved in a previous work, where I contributed to optimize
the  expression  and  purification  of  the  construct  (PhD  Thesis,  D.  Spiliotopoulos). In  the  next
paragraph, I will describe the structure of this tandem domain. 
4.1  NMR structural characterization of NSD1-P5C5. 
The tandem domain NSD1-P5C5 (residues Glu2115-Asp2206) is composed by two PHD finger
domains that adopt a compact fold and form an unique structural units stabilized by four zinc ions
coordinated by Cys-Cys-Cys-His motive (see Fig.1A and Fig.2A). 
The first module (NSD1-PHD5, or NSD1-P5) comprising residues Glu2115-His2162, assumes a
canonical PHD finger fold which contains a two-stranded antiparallel β-sheet (β1, residue Leu2130-
Ser2132 and β2 residues Val2141-Tyr2142) followed by a short α-helix (Ala2144-Leu2147, α1) and
the  loop  L3  (Leu2147-Cys2159).  The  α-helix  (Cys2159-His2162,  α2)  is  directly  linked  to  the
second PHD domain (NSD1-C5HCH or NSD1-C5) comprising residues Gln2163-Asp2206. This
module is a degenerate PHD finger domain which contains two short antiparallel beta sheets, β3-β4
(Ser2173-Phe2174; Ser2181-Phe2182) and β5-β6 (Leu2191-Ser2194; Gly2198-Cys2202) that are
arranged orthogonally to each other. 
The single domain fold is stabilized by a network of hydrophobic interactions involving Tyr2142,
Leu2147, Leu2149, Trp2157 in PHD5 and Phe2182, Leu2191, Ile2193 and Leu2200 in NSD1-
C5HCH  (see  Fig.2B).  Hydrophobic  residues  including  Phe2225,  Tyr2142,  Trp2261,  Phe2274,
Pro2279,  located  at  the  protein  interface,  establish  inter-domain  interactions  that  stabilize  the
protein  fold and create  a  hydrophobic  groove surrounded on both sides  by negatively  charged
residues (see Fig.1B and Fig.2C). 
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Fig.1. NSD1-P5C5 structure. (A) Cartoon representation of the NMR ensemble of the 15 lowest energy structures of NSD1-P5C5.
The NSD1-P5 and the NSD1-C5 domain are shown in light green and dark green, respectively.  (B) Electrostatic surface of
NSD1-P5C5. The structure in the left side of the panel has the same orientation as in panel A. The structure in the right side of the
panel is related to the former by a 180° rotation as indicated by the grey curved arrow. Blue and red indicate positive and negative
electrostatic surface potentials, respectively.
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Fig.2. NSD1-P5C5 structure (A) The secondary structure elements are indicated by labels, while the zinc coordinating residues are
shown in sticks. The zinc atoms are shown as black spheres.  (B) The side chains of the residues forming NSD1-P5C5 hydrophobic
core are shown as sticks (C) The hydrophobic residues that form the inter-domain interactions are shown in sticks.  
Lucio-Eterovic et al  2010 proposed a functional model in which NSD1 mediates the repression of
several gene involved in cellular growth and differentiation and the abrogation of this activity might
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contribute  to  pathological  conditions.  The Sotos  syndrome is  an overgrowth disorder,  probably
linked to  the  loss  of  NSD1 transcriptional  repression  activity  (Tatton-Brown e  Rahman  2007).
Interestingly,  about  two-thirds  of  pathological  point  mutations  target  the  NSD1-P5C5  domain
suggesting that this domain is functionally relevant in the pathology. In the next section, I will
describe the effect of these pathological point mutations on the protein fold. 
4.1.1  NSD1-P5C5  in  Sotos  Syndrome:  structural  analysis  of  NSD1-P5C5  pathological  point
mutations
Most of the Sotos pathological point mutations target the zinc-coordinating residues (Cys and His)
with  the  exception  of  Tyr2142Asn,  Arg2152Gln  and  Phe2182Ile  that  are  outside  the  zinc
coordinating sites. The cysteine mutants usually compromise the metal coordination a promoting
the protein unfolding.
In order to characterize the impact on the protein fold of the non-cystein pathological point mutants,
seven Sotos mutants have been generated (Tyr2142Asn,  His2143Glu, His2143Tyr,  Arg2152Gln,
His2162Arg, Phe2182Ile and His2206Arg) and analysed  by NMR spectroscopy comparing their
1H-1D spectra with the wild-type spectrum (see Fig3,4,5). 
The 1H-1D spectra of Tyr2142Asn and Phe2182Ile show broad lines and reduced peak dispersion
indicating that the mutations targeting the hydrophobic core of both domains strongly compromise
the tandem domain fold (see Fig. 3B,C).
The  His2143Glu and  His2143Tyr substitutions are detrimental for the protein fold and both the
spectra show that the protein is unfolded (see Fig. 3D,E) . 
Unexpectedly, the His2162Arg and His2206Arg substitutions, that target the second and the forth
zinc coordination site have a good chemical shift dispersion with respect to the 1H-1D spectra of
the other mutants (see Fig. 3A, 4A, 5A). However, the broad line width, and an increase in intensity
of the random coil signals (i.e. between 7.6 and 8.4 ppm) is indicative of a partial destabilization of
the  tertiary  fold.   In  order  to  better  investigate  the  fold  of  these  two pathological  mutants  we
collected 2D  1H  15N - HSQC spectra  of the protein domains and we compared them with the
spectrum of the wild type protein. The  1H  15N -HSQC spectrum His2162Arg is characterized by a
large  cluster  of  overlapped  peaks  in  the  middle  of  the  spectrum with  several  peaks  missing,
indicating the presence of significant unstructured elements in the protein. On the contrary, the 2D
spectrum of His2206Arg is a typical spectrum of a folded protein with well-dispersed peaks that can
be distinguished and assigned. The residues whose chemical shift is affected by point mutants are
the one that are close in sequence and in space to His2205, i.e. in the region comprising the strand
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β5-β6 as shown in Fig. 5.
Finally, the  1H-1D and H  15N -HSQC spectra of Arg2152Gln mutant are very similar to the wild
type tandem domain (see Fig. 6). The 2D spectrum displays well  dispersed signals typical of a
folded protein: in the structure the side-chain of Arg2152 is totally solvent exposed and probably
this residue has a functional rather than a structural role.
4.1.2 Summary
Conceivably NSD1-P5C5 Sotos pathological point mutations, lead to the loss of the protein domain
function.  In  this  thesis  we  studied  the  fold  of  seven  Sotos  mutations,  five  of  which  affect
hydrophobic  and  histidine  coordinating  residues  strongly  compromising  the  protein  fold.  We
observed that both His2162Arg and Arg2152Gln do not alter the protein fold. 
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Fig. 3 Structural characterization of  NSD1-P5C5 Sotos mutants.  (A) 1H-1D spectrum of wild-type NSD1-P5C5. In the Fig.
3B,C,D,E on the left are shown the 1H-1D  spectra of the NSD1-P5C5 Sotos mutants, on the right the residues affected by the
mutation are highlighted in red on the structure.
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Fig. 4 The NSD1-P5C5_His2162Arg fold  was analysed by NMR spectroscopy  (A) 1H-1D spectrum of  His2162Arg  on the left,
on the right is reported the NSD1-P5C5 structure with His2162 residue shown in red sticks. (B)1H  15N-HSQC spectrum of NSD1-
P5C5_His2162Arg (C) Superposition of the  1H  15N-HSQC spectrum of  NSD1-P5C5_His2162Arg (brown) and  1H  15N-HHSQC
spectrum of  NSD1-P5C5 (orange).  
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Fig.  5  The  NSD1-P5C5_His2205Arg  fold   was  analysed  by  NMR  spectroscopy  (A)  1H  1D  spectrum  of  NSD1-
P5C5_His2205Arg  on the left, while on the right is reported the NSD1-P5C5 structure with the His2205  residue shown in red sticks.
(B)  1H  15N-HSQC  spectrum  of  NSD1-P5C5_His2205Arg  (C)  Superposition  of  the  1H  15N-HSQC  spectrum  of   NSD1-
P5C5_His2205Arg (pink)  and  1H  15N-HSQC spectrum of   NSD1-P5C5 (orange).   (D) The histogram shows the difference of
chemical-shift, between the wild-type and mutant domain, for each residue of the   NSD1-P5C5_His2205Arg domain. Residues
displaying values over 0.1 ppm (orange line) were considered affected by the pathological mutation.  
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Fig. 6 Structural analysis of NSD1-P5C5_Arg2152Gln Sotos mutant (A) 1H 1D spectrum of NSD1-P5C5_ Arg2152Gln on the
left, on the right is reported the NSD1-P5C5 structure with Arg2152 shown in red sticks. (B) 1H 15N-HSQC spectrum of Arg2152Gln
(C) Superposition of the 1H15N-HSQC spectrum of NSD1-P5C5_Arg2152Gln (light green) and 15N-HSQC spectrum of NSD1-P5C5
(orange).
4.2 NMR structural characterization of Nizp1-C2HR 
4.2.1 Nizp1-C2HR binds Zn2+
Nizp1-C2HR belongs to the family of zinc finger domains in which the fourth zinc-coordinating
residue is missing. Generally, in the zinc finger proteins, the metal ion is tetra-coordinated by two
Cys and two His residues (Cys2His2) or three Cys and one His residue (Cys2HisCys). Nizp1-C2HR
contains  two Cys residues  (Cys407 and Cy410) and a  single  His  residue  (His423) that  should
constitute  the  zinc  binding motif..  Notably  the  fourth  coordinating  position  is  occupied  by  an
arginine (Arg427), an usual residue for zinc coordination.
Using a  synthetic  peptide  corresponding  to  Nizp-C2HR domain  (residues  Glu397-Lys434),  we
analysed the domain fold by NMR spectroscopy. We collected 1H 1D spectrum on a protein samples
that had been either depleted of zinc ions, adding EDTA and then dyalising agains NMR phosphate
buffer (see Fig.7, red spectrum),  or supplemented with ZnCl2 in molar ratio of 1:1 (see Fig.7, green
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spectrum). The comparison of the two spectra indicates that in the presence of zinc ions new peaks
appear  in  the  spectrum,  for  example  between  6  and  9.5  ppm,  and  their  dispersion  increases,
suggesting that the domain binds Zn2+, adopting its native fold in presence of a equimolar amount of
metal ions.
Fig. 7 Nizp1-C2HR is a zinc binding motif.  The green spectrum is collected using a protein sample of 0.2mM in presence of
equimolar amount of ZnCl2 at pH 6.3, while the red spectrum is collected using a protein sample without  ZnCl2 at pH 6.3. 
4.2.2   Optimization of Nizp1-C2HR recombinant protein preparation and labelling
In  order  to  perform  NMR  titrations  and  3D  heteronuclear  NMR  experiments  we  generated  a
recombinant  domain  corresponding  to  Nizp1-C2HR  module  (37  residues,  ~5kDa).  Adequate
expression conditions were found using a His(6)-MBP tag construct and the purification of mgs
amount of Nizp1-C2HR module was achived as described in Material and Method.  The fold of the
Nizp1-C2HR was checked  by 1H 1D NMR experiment and it was compared with the spectrum of
the  synthetic  peptide.  The  two  peptides  are  characterized  by  a  very  similar  peak  dispersion
suggesting that they adopt the same fold (see Fig. 8). 
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Nizp1-C2HR + 1 eq of ZnCl
2
Nizp1-C2HR without ZnCl
2
Fig. 8 Structural characterised of the Nizp1-C2HR recombinant protein fold by NMR spectroscopy. The  1H 1D NMR spectrum
of Nizp1-C2HR synthetic peptide (green) is superimposed to the spectrum of the recombinant protein domain (violet).
A sample with labelled in 15N was produced to acquire the 2D 1H 15N-HSQC of the protein domain,
while a sample labelled with 15N- 15C was used to collect HNCα 3D NMR experiment to assign its
backbone resonances. The 2D 1H 15N-HSQC of Nizp1-C2HR is reported in (see Fig. 9).
Fig. 9 Nizp1-C2HR backbone assignment (A) 2D 1H 15N-HSQC of Nizp1-C2HR (B) Selected strips extracted from of an HNCα
3D NMR experiment showing the assignment of  three sequential residues of Nizp1-C2HR. Initially the protein sequence is know,
but the assignment of HSQC is not. In the HNCα experiment each amide HN is correlated to its own Cα(i) and to the Cα of the
preceding residue (i-1).
4.2.3   Structure of Nizp1-C2HR 
We determined the structure of Nizp1-C2HR analyzing  both homonuclear (1H-1H TOCSY 1H-1H
NOESY) and heteronuclear multidimensional experiments (3D  1H  15N- SQC NOESY).  From the
anlysis  of  the 2D and 3D NOESY spectra  we collected 236 restrains that were converted into
interproton distances that were used in structure calculations 
Initial  calculations  performed without  a  zinc  ion,  highlighted  the  spatial  proximity  of  Cys407,
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Nizp1-C2HR synthetic peptide 
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Cys410 and His423, strongly suggesting their involvement in Zn2+ binding. The backbone carbonyl
group of Arg427 and the residue His433 did not appear to be involved in metal coordination as they
were  far away form these residues. 
The protonation state of the histidine residues was assessed using HMQC long range experiment.
For the His423 the spectrum shows that the correlations between the   Nε2 and both  Hε1 and Hδ2
(around 217 ppm) are stronger than the correlations between Nδ1 and Hε1, Hδ2 (at 174 ppm). This
result indicate that the  Nδ1 is protonated  and the metal binding, via the imidazole rings, occurs
through  Nε2. For the  His433 we could observe a set of correlations between  Nε2 and Hε1, Hδ2
around 180ppm and  between  Nδ1 and Hε1, Hδ2 near 190 ppm. This set  of peak correlations
indicate that Nδ1 and Nε2 are protonated, again suggesting that the His433 is not involved in the
coordination of the metal ion (see Material and Method). 
Fig. 10. The protonation state of the histidine residues: HMQC long range experiment. (A) 1H 15N long-range HSQC spectrum
of   15N-  labelled  Nizp1-C2HR.  Correlations  between the  peaks  are  highlighted  by  red  dashed  lines  for  Hi423 (B)  and  green
continuous lines for His433 (C).
A zinc ion was included in the subsequent and final calculations, assuming a coordination with tree
ligands.  In  the final  20 structures,  the  Nizp1-C2HR module fold  is  composed by  two-stranded
antiparallel β-sheet (β1 and β2 residues Tyr405-Cys407 and Gly411-Phe414, respectively) linked by
the loop (residues Arg415-Trp416) with the short  α-helix (residue Arg417-Arg425), while the N-
and C-terminal regions (Glu496-Ser502 and Ser426-Lys434, respectively) are largely unstructured
(see Fig.11A,B).
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The  structure  of  Nizp1-C2HR is  well  defined,  with  a  root-mean-square  deviation  (RMSD)  of
0.629±0.126 Å and 0.521±0.097 Å on the heavy atom and on the backbones, respectively, for the
region between the residues Ser404-Arg425 (see Fig.11A). This ββα fold is stabilized by a zinc ion
coordinated by thiol groups of Cys407, Cys410 and  Nε2  atom of His423 (see Fig. 13).  The side
chains of the residues Phe417, Phe420 and  His423 form the hydrophobic core of the finger and
stabilize its fold (see Fig12). In a classical C2H2 or C2HC zinc finger domain, the α-helix extends
up to the final chelating residue, whereas in Nizp1-C2HR fingers the helix ends shortly after the
position Arg425.  Interestingly, the structure of Nizp1-C2HR exhibits a large positive charge face
that could be involved in a protein-protein interaction (see Fig.11C).
Table 1. Structural Statistics of Nizp1-C2HR
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Fig 11. Nizp1-C2HR structure.  (A) Cartoon representation of the NMR ensemble of the 20 lowest energy structures of Nizp1-
C2HR. Superposition has been performed on the N, Ca and C' atoms of residues Ser401-Arg425  (B) Cartoon representation of the
Nizp1-C2HR with the N- and C-terminal regions (Glu496-Ser502 and Ser426-Lys434, respectively) (C) Electrostatic surface of
Nizp1-C2HR. The structure in the left side of the panel has the same orientation as in panel A. The structure in the right side of the
panel is related to the former by a 180° rotation as indicated by the curved arrow. Blue and red indicate positive and negative
electrostatic surface potentials, respectively.
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Fig12. Nizp1-C2HR hydrophobic core. The side chains of the residues forming Nizp1-C2HR hydrophobic core are shown as sticks.
Fig 13. Nizp1-C2HR zinc binding site. (A)The zinc binding site of Nizp1-C2HR in the circle (B) Close-up view of the zinc binding
site
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4.2.4  The structural role of Nizp1-C2HR-Asn409  and Nizp1-C2HR-Arg427 
In Nizp1-C2HR domain the Zn2+ coordination occurs through two Cysteins (Cys407 and Cys410)
and one Histidine (His423). The presence of only three coordinants is  sufficient to bind the Zn2+ ion
(Simpson et al. 2003) whereby the forth coordinants could be represented by a water molecule or a
carboxylic group of the protein residue, as observed in other Zn2+ binding proteins like in AFV1p06
where the  fourth ligand is  the  side-chain  oxygen atom of  the  carboxylic  group of  Glu residue
(Andreini et al. 2011, Guilliere F et al 2013).  
However, in 4 out of the 20 structures defining the NMR ensemble, the carbonyl group in the side-
chain of the residue Asn409 is close to the zinc ion binding site, suggesting a possible role in metal
coordination. In order to investigate this hypothesis we analyzed the effect on the domain fold when
the Asn409 is substituted by an alanine. The 1H 1D spectrum of Nizp1-C2HR-Asn409Ala mutant
was collected in the presence of  ZnCl2  in molar ratio of 1:1. The spectrum shows a good peak
dispersions and it is very similar (except for the peak that correspond to Asn409 around 9.1 ppm) to
the spectrum of wild-type domain bound to the zinc ions. This result indicates that the carbonyl-
group in the side-chain of Asn409 is not involved in the metal binding.
Fig 15 The zinc binding site of Nizp1-C2HR. The  position of the Asn409 residue in 4 structures.  
Fig 14. The Asn409 residue  is not a zinc ligand. Superposition of   1H 1D spectrum of Nizp1-C2HR wild type (green) 1H 1D
spectrum of Nizp1-C2HR-Asn409Ala mutant (cyan).
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In the Nizp1-C2HR sequence the fourth zinc ligand is substituted by arginine residue  (Arg427). By
means of two hybrid assay  Nielsen  et al  have studied the interaction between NSD1-P5C5 and
Nizp1-C2HR  and  Nizp1-C2HR  mutants  (called  Nizp1-C2HR-Arg427Ala  and  Nizp1-C2HR-
Arg427His, respectively) using two hybrid assays. In their experimental conditions they observed
that only the the Nizp1-C2HR-Arg427Ala mutant was able to bind with NSD1-P5C5. 
These results prompted us to investigate the fold and the interaction of these mutants with NSD1-
P5C5 by NMR experiments.  To this aim we generated by site directed mutagenesis the Nizp1-
C2HR-Arg427Ala  mutant  and  we  synthesized  the  peptide  corresponding  to  Nizp1-
C2HR_Arg427His mutant.  The Nizp1-C2HR_Arg427Ala  and Nizp1-C2HR_Arg427His fold has
been studied by  1H 1D, 1H-1H TOCSY and 1H-1H NOESY NMR spectra.  We observed that the 1H-
1D NMR spectrum of Nizp1-C2HR_Arg427Ala is  is  well  dispersed indicating that the domain
maintains its protein fold  (see Fig.16). The result  was confirmed by  1H-1H  TOCSY and1H-1H
NOESY spectra that indicated that for the domain establishes similar intermolecular NOEs as wild-
type.
Fig 16. The Arg427Ala mutation does not affect the motif fold. (A) The  position of the Arg427 residue in the NMR structure. (B)
Superposition of  1H 1D spectrum of Nizp1-C2HR wild type (green) 1H 1D spectrum of Nizp1-C2HR_Arg427Ala mutant (orange).
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In the Nizp1-C2HR_Arg427His mutant (see Fig 17), inter-residue NOEs indicate that His427 is
near the zinc binding site suggesting an involvement of this residues in metal coordination. Based
on the experimental restrains obtained from the analysis of the NOESY spectra we determined the
structure of the Nizp1-C2HR_Arg427His: the solution structure is similar to the wild-type one,
whereby the  α-helix is slightly longer as compared to the wild type. The extension after position
427 is due to the presence of the additional histidine,  that coordinates the zinc ion inducing an
additional helical turn (see Fig 18). 
Fig 17.  Structural  characterization of  the Nizp1-C2HR_Arg427His mutant domain.  Superposition of  1H 1D spectrum of
Nizp1-C2HR wild type (green) 1H 1D spectrum of Nizp1-C2HR-Arg427His mutant (light blue).
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Fig.18  Structural  characterization  of  Nizp1-C2HR_Arg427His  mutant  domain.  (A)  Cartoon  representation  of  Nizp1-
C2HR_Arg427His  (in  green)  and  its  zinc  binding  site  (B  and  D).  (C)  Superposition  of  Nizp1-C2HR  (orange)  and   Nizp1-
C2HR_Arg427His (green)
4.2.5   Summary
Nizp1-C2HR is a zinc finger domain that contains three zinc coordinating ligands in the metal
binding  motif.  Interestingly,  the  Nizp1-C2HR synthetic  peptide  assumes  its  native  fold  in  the
presence of zinc ions suggesting that two Cys and one His are sufficient for Zn2+  coordination. In
orde to perform multidimensional NMR experiments, we produced this small zinc finger domain
(37  residues)  as  fusion  protein  in  bacteria  and  the  purified  recombinant  module  folds  as  the
synthetic peptide. We solved the NMR structure of Nizp1-C2HR, it adopts a typical zinc finger fold
with  a  two-stranded  antiparallel  β-sheet  and  a  short  α-helix  that  ends  after  the  coordinating
histidine.  The  structural  analysis  of  Nizp1-C2HR-Asn409Ala  and  Nizp1-C2HR-Arg427Ala  and
Nizp1-C2HR-Arg427His mutants, reveals that the mutants are well folded and that insertion of a
forth Zn2+ coordinating residue extends the domain helix by one helical turn. The solved structures
of  NSD1-P5C5  and  Nizp1-C2HR  are  the  pre-requisite  for  the  structural  studies  that  will  be
described in the following chapters.
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4.3 Characterization of the interaction between NSD1-P5C5 and Nipz1-C2HR 
4.3.1 Introduction
NMR chemical-shift mapping method is a highly sensitive tool to prove binding and to map binding
sites in protein-protein interactions (Rajagopal et al 1997). It requires 15N-labeled protein in order to
record 2D 1H-15N HSQC spectra before and after the addition of increasing amounts of the ligands.
The HSQC provides the correlation between the nitrogen and amide proton, and each amide yields a
peak in the HSQC spectrum. Peaks corresponding to a residue involved in the recognition process
might move, duplicate or broaden depending on the exchange regime of complex formation  (see
Material and Methods). In the system object of our study we have two protein domains (NSD1-
P5C5 and  Nizp1-C2HR)  and  using  NMR chemical-shift  mapping  method  we  can  identify  the
binding surface on both of them. In order to identify the protein backbone NH groups affected by
the binding,  we performed NMR titrations  of  15N labelled NSD1-P5C5 with unlabelled Nizp1-
C2HR and reversed titrations where 15N  labelled Nizp1-C2HR was titrated with  unlabelled NSD1-
P5C5.
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4.3.2   Identification of the binding surface on NSD1-P5C5
The  NMR  titration  of  15N-NSD1-P5C5  with  unlabelled  Nizp1-C2HR  synthetic  peptide  was
performed up to final 1:1 ratio. In Fig. 19 in blue is reported the 2D   1H  15NHSQC spectrum of
NSD1-P5C5 in free state and in red the spectrum of the complex NSD1-P5C5:Nizp1-C2HR (see
Fig 19A,B). Superposition of the two spectra shows that several peaks move in the spectra upon
Nizp1-C2HR addition suggesting that the two proteins interact directly. The exchange regime of the
reaction is slow in the chemical-shift time scale: residues affected by the binding show reduction of
their peak intensities at sub-stoichiometric ratio, while new peaks, belonging to the protein in the
bound form, appear at different chemical shifts, with an increasing intensity upon ligand addition
(see Fig 19C).
Fig. 19: NSD1-P5C5 binds Nizp1-C2HR. (A) 1H 15N-HSQC spectrum of NSD1-P5C5 in free state (blue). (B) 1H 15N-HSQC spectra
resulting from the titration. Shown in blue the spectrum of the free NSD1-P5C5. The red spectrum corresponds to the same sample
after the addition of 1 equivalent of Nizp1-C2HR. (C) Close-up view of two peaks during the NMR titration. The exchange regime of
the reaction is slow in the chemical-shift time scale: with the progressive addition of ligand, new resonances appear at the chemical
shift of the bound form, whereas the resonances of the free state progressively disappear.
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The  residues  shifting  upon peptide  addition  were  identified  performing 3D NMR experiments,
HNCα and CβCα(CO)NH spectra (see Material and Methods), that permit to assign the backbone
NH group of  NSD1-P5C5 in complex with Nizp1-C2HR. 
To compare the free and the bound forms, the chemical shift displacements (CSDs) of the protein
backbone NH groups upon ligand addition are reported in the histogram (Fig. 20A). We can observe
that the backbone NH groups of the first PHD finger are more perturbed than the NH groups of the
second module. In the CSD plot we considered NSD1-P5C5 aminoacids significantly affected by
ligand binding those residues showing a CSD higher than the average (green line) plus one standard
deviation (red line) (see Fig. 20A) and these residues are Asp2119, Phe2122, Ser2123, Cys2124,
His2143, Leu2147, Trp2157, Glu2158, Met2177. 
Also the chemical-shift of the Cα and Cβ in the residue side-chains were perturbed by the binding
event and provided information about the interaction surface. The differences of the Cα and Cβ
chemical shift are plotted in the histograms in Fig. 20C and D and we  considered significant the
residues whose CSDs is equal or higher than 0.5 ppm. The amino acids involved in the interaction
are  Phe2122,  Ser2123,  Cys2124,  Ser2132,  Cys2133,  His2143,  Tyr2142,  Cys2146,  Leu2147,
Ala2152,  Trp2155,  Glu2156,  Glu2176,  Cys2178,  Pro2179,  Ser2180,  Ser2181,  Glu2204  and
His2205. All the residues affected by the binding were mapped on the tandem domain structure (see
Fig. 20D). 
The majority of these residues clustered around a common region localized at the interface between
the PHD finger tandem domain, while other residues far from this region are indirectly affected by
the  interaction.  In  the  tandem  protein  domain  structure  the  interface  region  between  the  two
modules is composed by hydrophobic residues that form direct inter-domain interactions, creating
an hydrophobic groove surrounded on both sides by negatively charged residues that can establish
polar contacts and hydrophobic interactions with the Nizp1-C2HR (see Fig. 20).
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Fig.20 Binding site mapping on the surface of the NSD1-P5C5 domain. (A) The histogram shows the backbone NH group
Chemical  Shift  Displacement  (CSD,  in  ppm)  value  per  each  assigned  residue  of  NSD1-P5C5  in  complex  with  Nizp1-C2HR.
Residues displaying values higher than the average (green line) plus one standard deviation (red line) were considered for the Nizp1-
C2HR binding site map. (B) and (C) The histograms show the differences of the Cα and Cβ chemical shift, respectively. Residues
displaying values over 0.5 ppm (red line) were considered significantly affected by the binding. (D)Representation of the Nizp1-
C2HR binding site on the surface of the NSD1-P5C5 domain. Residues displaying a significant CSD are coloured in red. The NSD1-
P5 is coloured in light green, while the NSD1-C5 is coloured in dark green.   
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4.3.2   Identification of the binding surface on Nizp1-C2HR
The  recombinant  Nizp1-C2HR domain  was  labelled  with  15N and  used  in  NMR titration  with
unlabelled NSD1-P5C5.  An overlay of the 2D 1H-15N HSQC spectra of free Nizp1-C2HR (brown)
and in the presence of NSD1-P5C5 (blue, final ratio 1:1) is shown in Fig. 21. The interaction is in
the slow exchange regime in the chemical shift time scale and several peaks move in the spectrum.
The  backbone  of  Nizp1-C2HR  in  complex  with  NSD1-P5C5  was  assigned  by  3D  NMR
experiments (HNCA experiment, see Material and Method). The chemical shift displacements of
the protein backbone NH groups free and bound to NSD1-P5C5 are plotted in the histogram in Fig.
22. Residues showing CSD higher than the average (green line) plus one standard deviation (red
line) included Arg417, Val418, Phe420, Arg422 and His423 (Fig. 22A).  As described before for
NSD1-P5C5, we also considered the chemical-shift perturbations of the Cα to identify the binding
surface. The residues whose CSDs were higher than of 0.2 ppm are localized on the second β2-
strand (Lys412, Phe414), on the loop (Trp416) and on the short α-helix  (Arg417, Val418, Asn419,
Phe420, Ile421, Arg422). The majority of these residues clustered on the short  α-helix suggesting
that this structural element is involved in the interaction.
Fig. 21. Nizp1-C2HR binding to the NSD1-P5C5 monitored by NMR. (A) 1H 15N HSQC spectrum of Nizp1-C2HR in free state
(blue). (B) 1H 15N HSQC spectra resulting from the titration of increasing amounts of unlabelled NSD1-P5C5 domain on a  1H 15N
-Nizp1-C2HR sample (C) Close-up view of two peaks during the NMR titration. The exchange regime of the reaction is slow in the
chemical-shift time scale. 
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Fig.22: Binding site mapping on the surface of the Nizp1-C2HR domain. (A) The histogram shows the backbone NH group
Chemical Shift Displacement (CSD, in ppm) value for each assigned residue of Nizp1-C2HR in complex with NSD1-P5C5 Residues
displaying values higher than the average (green line) plus one standard deviation (red line) were considered for the binding site map.
(B) The histograms show the differences of the Cα. Residues displaying values over 0.2 ppm (red line) were considered significant
affected by the binding. (C) Representation of the NSD1-P5C5 binding site on the surface of the Nizp1-C2HR domain. Residues
displaying a significant CSD are coloured teal.
4.3.3 Summary 
By means of NMR titrations we have validated and characterized the interaction between NSD1-
P5C5 and Nizp1-C2HR. Using the CSDs we identified the binding surface both on NSD1-P5C5 and
Nizp1-C2HR. For NSD1-P5C5, we observed that both the PHD finger domains are involved in the
interaction. In particular, the interface region between the two domains, composed by hydrophobic
and negatively charged residues, forms the binding pocket for the zinc finger domain. For Nizp1-
C2HR, the CSDs indicates that the short α-helix is involved in the interaction. In the next chapter
the thermodynamic parameters that govern this protein-protein interaction will be presented. 
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4.3.4 Thermodynamic characterization of the interaction between NSD1-P5C5 and Nizp1-C2HR
Isothermal titration calorimetry experiment were performed to determine the binding affinity and
the binding enthalpy and entropy of the interaction between NSD1-P5C5 and Nizp1-C2HR. The
heat of the interaction of Nizp1-C2HR (200 μM) with NSD1-P5C5 (15 μM) was determined in
20mM phosphate buffer, 150 mM of NaCl and 2mM β-mercaptoethanol at pH 7.2 and 23°C. Fig.
23  shows the typical titration for this interaction. 
Under these conditions, complexation of NSD1-P5C5 and Nizp1-C2HR was endothermic (positive
peaks in the ITC output)  with saturation around 1:1 stoichiometry.  Integrated heat data yielded
thermal binding curve that could be analyzed by standard nonlinear regression methods to give
estimates of the binding stoichiometry (n), equilibrium affinity constant (Ka) for the association (Ka
=1/Kd, where Kd  is the dissociation constant), and the enthalpy of binding (ΔH), see Fig. 23. To
estimate  accurate  enthalpy  value  the  contributions  of  the  buffer  enthalpy  and  protein  dilution
enthalpy in sample cell were subtracted to   the enthalpy of the reaction. The free energy of the
reaction (ΔG) was calculated from the relationship  ΔG = -RTInKa , and the change in entropy (ΔS)
was calculated from T ΔS =  ΔH -  ΔG (see Fig. 23). 
The  measured   Kd  is  in  the  range  of  μM  that  is  typical  for  this  biological  system  and,  the
stoichiometry of the reaction is 1 as indicated by the value of n close to 1. The binding reaction is
characterized by enthalpically unfavourable (ΔH>0) but entropically favourable (ΔS>0) process and
the large positive entropy is compensated by a small positive enthalpy change. This data suggest
that the reorganization of the ordered solvation network and the exclusion of water molecules from
the complex surface (these contributes are entropically favourable) are the driving force of the
reaction. 
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Fig. 23.  ITC titration of Nizp1-C2HR motif on the NSD1-P5C5 domain. The measured differential heat in function of time is
shown in the top panel. The lower panel shows the integrated data and the calculated residuals in function of the ligand molar ratio,
as well as the fitted binding isothermal. The thermodynamic parameters are displayed in the table in the right.  
4.3.5  Characterization  of  the  interaction  between  NSD1-P5C5 pathological  point  mutants  and
Nizp1-C2HR
The  NSD1-P5C5 Sotos  pathological  point  mutations  conceivably  lead  to  a  loss  of  the  protein
domain  function.  As  previously  described  (chapter  3.1.1)  we  studied  the  fold  of  seven  Sotos
mutations.  Five  of  these  mutations  that  affect  hydrophobic  and  histidine  coordinating  residues
strongly compromise the protein fold, whereas His2162Arg and Arg2152Gln mutations preserve the
protein fold. 
In this section, in order to investigate the role of NSD1-P5C5 under pathological conditions we
characterized the interaction between the Arg2152Gln and His2162Arg mutants and Nizp1-C2HR. 
We followed the amide resonances shifts of uniformly  15N-labeled  NSD1-P5C5_Arg2152Gln  and
NSD1-P5C5_His2206Arg mutants upon the addition of unlabelled  Nizp1-C2HR. Both reactions
were in slow-exchange regime in the chemical-shift time scale. In the first experiment  we observe
binding between NSD1-P5C5_Arg2152Gln and Nizp1-C2HR, (see Fig. 24A). The superposition of
the 2D spectra (see Fig.24B) of the the complex  15N-NSD1-P5C5_Arg2152Gln:Nizp1-C2HR and
15N-NSD1-P5C5:Nizp1-C2HR shows that the entity of the shifts of the mutant protein upon Nizp1-
C2HR are comparable to the wild-type protein, suggesting a similar interaction pattern and a similar
interaction strength. These results indicate that the Arg2152Gln substitution doesn't compromise the
interaction  with  Nizp1-C2HR  and  that  the  binding  is  structurally  similar.  In  the  NSD1-P5C5
structure the Arg2152 is localized far from the putative binding surface mapped on tandem domain
structure (see chapter 4.3.2, and Fig 24E) suggesting that this residue is not involved in protein-
protein interaction. 
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Fig.24  :  NSD1-P5C5_Arg2152Gln  binds  Nizp1-C2HR.  (A)  HSQC spectra  of  the  15N-NSD1-P5C5_Arg2152Gln in  free  state
(green) and bound to Nizp1-C2HR (brown). (B)Superposition of the HSQC spectra of the  15N-NSD1-P5C5:Nizp1-C2HR complex
(red) and  15N-NSD1-P5C5_  Arg2152Gln:Nizp1-C2HR (brown). (C)Histogram representation of the chemical shift displacement
(CSD) observed per each residue. (D) Superposition of the CSD plots resulting from the NMR titration with wild-type NSD1-P5C5
(red) and NSD1-P5C5_Arg2152Gln (black). (E) Position of the Arg2152 residue.
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The second pathological  substation,  NSD1-P5C5-His2206Arg, is  near the Nizp1-C2HR binding
pocket to (see Fig. 26). 
Fig. 26 Localization of the His2205 residue. The Nizp1-C2HR binding surface is shown in red, the surface of the His2205 residue
is coloured in blue.
The NMR titration (see Fig.  27A) indicates that the two protein domains interact, however the
entity of the shifts upon Nizp1-C2HR addition is smaller as compared to the wild-type protein,
suggesting a weaker interaction for this mutant (see Fig. 27B).
Finally comparison  between CSDs of the wild-type protein with those of NSD1-P5C5_His2206Arg
and  with  those  of  NSD1-P5C5_Arg2152Gln  upon  binding  to  Nizp-C2HR  shows  that  the
His2206Arg mutant has an higher impact in complex formation as compared to Arg2152Gln  (Fig.
28). For a quantitive valuation of the impact of these mutations on binding to  Nizp1-C2HR in
future we measure by ITC titration the association constant between the pathological mutants and
Nizp1-C2HR.
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Fig.27: NSD1-P5C5_His2206Arg binds Nizp1-C2HR. (A) HSQC spectra of the 15N-NSD1-P5C5_His2206Arg in free state (pink)
and bound to Nizp1-C2HR (teal). (B)Superposition of the HSQC spectra of the  15N-NSD1-P5C5:Nizp1-C2HR complex (red) and
15N-NSD1-P5C5_His2206ArgNizp1-C2HR (teal). (C)Histogram representation of the chemical shift displacement (CSD) observed
per each residue. (D) Superposition of the CSD plots resulting from the NMR titration with wild-type NSD1-P5C5 (red) and NSD1-
P5C5_His2206Arg (black).
Fig.28. The binding mode of NSD1-P5C5_Arg2152Gln and  Nizp1-C2HR.NSD1-P5C5_His2206Arg. (A) The histogram shows
the differences in CSDs between the wild-type NSD1-P5C5 domain and NSD1-P5C5_Arg2152Gln mutant. (B)The histogram shows
the differences in CSDs between the wild-type NSD1-P5C5 domain and NSD1-P5C5_His2206Arg mutant. 
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4.3.6 Summary 
In this chapter we have characterized the effects of the pathological point mutants on the protein
interaction activity of NSD1-P5C5. The CSDs indicate that the Arg2152Gln substitution does not
compromise  the  protein  binding  with  the  Nizp1-C2HR  while  the  His2206Arg  influences  the
interaction with the zinc finger module.  Most likely diminishing the interaction strength.
In the following section we will investigate the role in protein-protein interaction of Nizp1-C2HR_
Asn409, the residue near the metal binding site, and Nizp1-C2HR_Arg427, the residue that was
supposed to substitute the fourth zinc coordinating ligand and that is part of the C2HR signature. 
4.3.7 F  unctional role of Nizp1-C2HR-Asn409 and Nizp1-C2HR-Arg427
In the sections 3.4.5 and 3.4.3 we have characterized the structure of Nizp1-C2HR-Asn409, Nizp1-
C2HR-Arg427Ala and Nizp1-C2HR-Arg427His mutants. In this paragraph, the interactions of these
three mutants with NSD1-P5C5 and mutants were investigated by NMR titrations. 
We did three experiments,  in which  15N-NSD1-P5C5 was titrated either with unlabelled Nizp1-
C2HR-Asn409, or with unlabelled Nizp1-C2HR-Arg427Ala, or with Nizp1-C2HR-Arg427His (see
Fig. 29, 30, 31). 
The three NMR titrations indicate that NSD1-P5C5 interacts equally well with the three mutants. In
Fig 29B, 30B, 31B is reported an overlay of the 2D 1H-15N HSQC spectra of the complex formed by
15N-NSD1-P5C5:Nizp1-C2HR (in red) and in green, orange and blue the spectra of the complex
composed  by  15N-NSD1-P5C5:Nizp1-Asn409, 15N-NSD1-P5C5:Nizp1-C2HR-Arg427Ala,  15N-
NSD1-P5C5:Nizp1-C2HR-Arg427His  and  15N-NSD1-P5C5:Nizp1-Asn409,  respectively.We
observed that the peaks in the three  1H-15N HSQC spectra have similar chemical shift dispersion
suggesting that the mutations do not compromise the protein-protein interaction. 
The 1H-15N  HSQC  spectra  of  the  three  complexes  were  assigned  and  the  chemical-shift
perturbations were plotted in three histograms, see Fig. 29C, 30C, 31C. The residues of NSD1-
P5C5 affected by the binding event with Asn409Ala and Nizp1-C2HR-Arg427Ala/His mutants are
the same as the one involved in interaction with the Nizp1-C2HR wild type domain see Fig. 29D,
30D, 31D.  The differences of CSDs between the Nizp1-C2HR wild-type domain and its mutants
are smaller than 0.04 ppm (Fig. 29E, 30E, 31E). Collectively, these results suggest that the three
mutant domains and the wild type zinc finger module interact with the same binding surface and
that  the Arg427 and Asn409 side-chain not directly involved in the recruitment. The  Arg427His
substitution, induces a conformational change  that extends the fold of the α-helix but  does not alter
its protein interaction activity. This data indicates that only the α-helix region between the residues
Arg417-His423 is involved in the binding.
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Fig  29:  NSD1-P5C5  binds  Nizp1-C2HR_Asn409Ala.  Data  resulting  from  NMR  titration  of  the  unlabelled  Nizp1-
C2HR_Asn409Ala on a 15N-NSD1-P5C5 domain sample (A) HSQC spectra resulting form the NMR titration  of 15N-NSD1-P5C5
with Nizp1-C2HR_Asn409Ala. In brown the HSQC spectrum of the free 15N-NSD1-P5C5 domain and in green the HSQC spectrum
of the  15N-NSD1-P5C5 domain bound to Nizp1-C2HR_Asn409Ala.  (B) Superposition of the HSQC spectra of the  15N-NSD1-
P5C5:Nizp1-C2HR complex (red)  and  15N-NSD1-P5C5-C2HR_Asn409Ala complex (green).  (C)Histogram representation of the
chemical shift displacement (CSD) observed per each residue of the NSD1-P5C5 domain titrated with Nizp1-C2HR_Asn409Ala .(D)
Superimposition of the CSD plots resulting from the NMR titration of the NSD1-P5C5 domain with wild-type Nizp1-C2HR (red)
and Nizp1-C2HR_Asn409Ala (black). (E) The histogram shows the differences in CSDs upon binding to Nizp1-C2HR and Nizp1-
C2HR_ Asn409Ala.
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Fig.30:  NSD1-P5C5  binds  Nizp1-C2HR_Arg427Ala.  Data  resulting  from  NMR  titration  of  the  unlabelled  Nizp1-
C2HR_Arg427Ala on a 15N-NSD1-P5C5 domain sample (A) HSQC spectra resulting form the NMR titration  of  15N-NSD1-P5C5
with Nizp1-C2HR_Arg427Ala. In brown the HSQC spectrum of the free 15N-NSD1-P5C5 domain and in green the HSQC spectrum
of the  15N-NSD1-P5C5 domain bound to Nizp1-C2HR_Arg427Ala.  (B) Superposition of the HSQC spectra of the  15N-NSD1-
P5C5:Nizp1-C2HR complex (red)  and  15N-NSD1-P5C5-C2HR_Arg427Ala complex (green).  (C)Histogram representation of the
chemical shift displacement (CSD) observed per each residue of the NSD1-P5C5 domain titrated with Nizp1-C2HR_Arg427Ala. (D)
Superimposition of the CSD plots resulting from the NMR titration of the NSD1-P5C5 domain with wild-type Nizp1-C2HR (red)
and Nizp1-C2HR_ Arg427Ala (black). (E) The histogram shows the differences in CSDs upon binding to Nizp1-C2HR and Nizp1-
C2HR_Arg427Ala.
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Fig.31:  NSD1-P5C5  binds  Nizp1-C2HR_Arg427His.  Data  resulting  from  NMR  titration  of  the  unlabelled  Nizp1-
C2HR_Arg427His on a 15N-NSD1-P5C5 domain sample (A) HSQC spectra resulting form the NMR titration  of  15N-NSD1-P5C5
with Nizp1-C2HR_Arg427His. In brown the HSQC spectrum of the free 15N-NSD1-P5C5 domain and in green the HSQC spectrum
of the  15N-NSD1-P5C5 domain bound to Nizp1-C2HR_Arg427His.  (B) Superposition of the HSQC spectra of the  15N-NSD1-
P5C5:Nizp1-C2HR complex (red) and  15N-NSD1-P5C5-C2HR_ Arg427His complex (green). (C) Histogram representation of the
chemical shift displacement (CSD) observed per each residue of the NSD1-P5C5 domain titrated with Nizp1-C2HR_Arg427His . (D)
Superimposition of the CSD plots resulting from the NMR titration of the NSD1-P5C5 domain with wild-type Nizp1-C2HR (red)
and Nizp1-C2HR_ Arg427His (black). (E) The histogram shows the differences in CSDs upon binding to Nizp1-C2HR and Nizp1-
C2HR_Arg427His.
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4.4. Crystallization screening 
In order to better understand the structural basis of the interaction between NSD1-P5C5 and Nizp1-
C2HR we aimed to solve the structure of the protein complex by protein crystallography.  The
crystallization trials were performed on a 1:1 complex.
In the first step we searched the optimal concentration of the protein sample by a pre-crystallization
test (PCT kit, from Hampton Research). We tested three initial sample concentrations, 5 mg/ml, 10
mg/ml and 15 mg/ml, using the four conditions of the kit (reagents: A1,B1,A2,B2. See Material and
Method). We observed that at 5 mg/ml the protein complex did not precipitate in any condition of
the kit (the crystallization drops were clear), while at 10 mg/ml and 15 mg/ml we observed that it
precipitated  heavily.   Following  the  protocol  we diluted  the  protein  sample  to  7.5  mg/ml  and
repeated the test. In this case, we observed a light granular precipitate in the A1/B1 reagents and no
precipitation  for  the  protein  complex in  A2/B2 reagents.  This  result  indicated  that  the  optimal
concentration to perform the following screenings was around 7.5 mg/ml.  
Next, we performed two commercial screenings (Index and the Crystal-screen), which allowed us to
test  146  different  conditions.  After  one  week  we  selected  a  condition  in  which  we  observed
evidence of nucleation (0.15 M magnesium chloride hexahydrate, 0.1 M BIS-TRIS ph6.5, 25% w/v
PEG3.350).  Nucleation is the initial formation of the molecular clusters from which the crystals
grow (see Fig 32 A). Using as starting point this condition, we performed a more rigorous screening
around  it,  varying  the  pH,  the  salt  and  precipitant  concentrations.  The  better  result  of  this
optimization of the conditions was found in 0.1 M BIS-TRIS pH 6.5, 0.3 M magnesium chloride
hexahydrate  and  27% w/v PEG3.350. Single  crystal  were obtained,  but  further screenings are
needed to increase the size and thickness of them.   
 
Fig 32 Crystallization screening. (A) The small spheres correspond to the nuclei of the nucleation process  (B) Single crystal of the
complex NSD1-P5C5:Nizp1-C2HR.
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4.5. Molecular modelling of the  NSD1-P5C5 and  Nizp1-C2HR complex
A model of the NSD1-P5C5 and Nizp1-C2HR complex has been computed by HADDOCK server
using the experimental  data  from the NMR titrations.  The HADDOCK server  is  a  data  driven
docking program commonly used to generate three-dimensional model of interacting proteins using
experimental  data.  The structure of  NSD1-P5C5 has  been docked onto  the structure of  Nizp1-
C2HR, using as restrains the residues shifting in NMR titrations. In particular, for both domains, we
use as active residues the residues whose backbone NH groups are affected by the binding and as
passive residues the residues whose carbon atom CSDs is equal or higher than 0.5 ppm. After the
calculation HADDOCK clustered 162 structures in 10 clusters. Fig 33  shows the HADDOCK score
(intermolecular energy, see Material and Method) as a function of the iRMSD (backbone RMSD at
the interface) from the target, that is the the lowest energy complex structure. The cluster 3 is the
best cluster with a HADDOCK score of -145.0±9.1, iRMSD = 1.5±0.8 Å  and a Z-score of -1.5.
The statistic of the cluster is reported in the Table 2.
Fig 33. Graphic representation of the HADDOCK score in function of iRMSD
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Table 2. Statistic NSD1-P5C5:Nizp1:C2HR HADDOCK complex.
The model suggested that the formation of the complex involves the NSD1-P5C5 residues at the
interface between the two PHD domains and the short  α-helix of Nizp1-C2HR as indicated by
CSDs  (see  Fig.  34).  The  interaction  is  stabilized  by  hydrophobic  contacts  and  polar  contacts
between the two protein domains. Specifically, the Ser2143, Asp2165 and Glu2204 of NSD1-P5C5
interact with the Asn419, Arg422 and Arg417 of Nizp1-C2HR, respectively. The aromatic residue
Trp416 of Nizp1-C2HR establishes hydrophobic interaction with the side-chain of Phe2122 and
Met2177 of NSD1-P5C5. In future, we aim to improve this model adding to the docking calculation
the  molecules  NOEs  between  the  two  proteins  and  then  validate  the  model  by  site-specific
mutagenesis.  
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Fig 34 Haddock model of NSD1-PD5C5:Nizp1-Nizp1-C2HR complex. (A) On the left, cartoon representation of the complex
model  computed  using  the  experimental  data  from  the  NMR  titrations.  The  binding  surface  is  coloured  in  red.  On  the  left
Electrostatic  surface of  NSD1-P5C5.  The charge residueS  of  the Nizp1-C2HR are  shown as  stick (B) Close up view of  the
interactions that stabilize the protein complex.
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5. Discussion 
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5.1 Introduction 
The histone lysine methyltransferase NSD1 (Nuclear SET domain containing protein-1) is a
transcriptional regulator that is important in the control of the expression levels of genes
involved in  development and differentiation. The divalent specificity to methylated H4K20
and H3K36 determines its involvement  in gene silencing and activation (Rayasam et  al
2003).  NSD1 is  a  multi-modules  protein  that  contains a  SET domain,  PHD finger  and
PWWP domains that are typically involved in  numerous epigenetic events. This domain
architecture  is  a  common  feature  in  human  transcription  factors.  For  example,  the
MLL1/KMT2A, a SET-domain containing protein, contains three consecutive PHD finger
domains in  the N-terminal  part,  mediating gene repression,  and one PHD finger-Bromo
tandem domain, in C-terminal region, having  transcriptional activator function (Muzaffar
A. et al 2013). 
NSD1 plays a key role in human diseases: chromosomal translocation and point mutations
in  NSD1  gene  are  linked  with  acute  myeloid  leukemia  (AML)  and  overgrowth  Sotos
Syndrome, respectively.  In particular, NSD1 gene fusion to NUP98 leads to 5% of human
acute myeloid leukemia cases. The binding of the chimeric protein to its genetic targets is
essential for leukaemogenesis and it is mediated by NSD1-P5C5 (Wang et al 2007). The
physiological  importance  of  this  tandem domain  is  further  highlighted  by  the  fact  that
numerous mutations associated with Sotos syndrome lie in this two PHD domains.  It was
proposed that NSD1-P5C5 works both as histone reader and as mediator that interacts with
the C2HR zinc finger domain of the transcriptional repressor Nizp1 (Nielsen et al. 2004). 
Nizp1 contains five zinc finger modules, that in tandem array display DNA and protein
interaction activities, and a KRAB domain that has been shown to silence the transcription
through the recognition of the corepressor protein TIF1β/KAP-1 (Abrink M et al 2001). It
was speculated that the binding of NSD1 to Nizp1, probably mediates NSD1 recruitment on
the chromatin leading to gene repression (Nielsen et al. 2004). 
Biochemical or genetic studies should be assisted by further biophysical studies  to better
understand  this  protein-protein  interaction  mechanism  between  two  or  more  functional
units. The molecular details on the interaction of NSD1-P5C5 with Nizp1-C2HR, presented
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in this work, enabled us to explain the at molecular levels structural determinants at the
basis of the interaction between a PHD finger and a zinc finger motif. This is the first time
to our knowledge that an interaction between two zinc binding domains has been described
at structural level.  In the following I will discuss the structural and thermodynamic features
of the interaction, that have been studied in this thesis.
5.2 NSD1-P5C5 is a tandem PHD finger involved in Sotos Syndrome. 
The NSD1-P5C5 NMR structure shows that the NSD1-PHD5 presents the typical fold of
the PHD fingers, while the C5HCH domain displays an atypical topology for a PHD finger
with two additional antiparallel β strands in the C-terminal region. The two domains have a
large interface region that holds them together and determines the formation of a  highly
negatively charged concave surface between the two domains (see Fig.1). 
Overall the tandem domain creates a single structural unit, similarly to what observed in the
homologue NSD3-P5C5 structure (RMSD = 1.49 Å) adopting a “face to side orientation” at
variance to what observed in other tandem PHD fingers such as the tandem domains of
MOZ (monocytic leukemia zinc finger protein, a histone acetyltransferase) or of Dpf3b (an
adaptor  component  of  BAF chromatin  remodeling  complex)  that  adopt  a  “head  to  tail
orientation” (Dreveny I et al 2013, Zeng L et al 2010). The different domains orientation
determines  that  MOZ  and  Dpf3b  recognize  the  unmodified  N-terminal  residues  and
acetylated K14 of  H3 with PHD2 and PHD1 respectively,  wheres NSD3-P5C5 forms a
complex with H3 N-terminal peptide only through the first PHD (NSD3-PHD5 or NSD3-
P5) of the tandem module (see Fig. 35). 
NSD3-P5C5 was identified as an epigenetic module able to recognize the trimethyled K9 on
the H3 histone tail with low binding affinity (290 ±8 μM) but no binding was detected with
Nizp1-C2HR by GST-pull down (He C et al 2012). Interestingly, NSD1-P5C5 and NSD3-
P5C5 share  about  65% sequence  similarity  and high structural  homology,  however our
NMR titration and ITC experiments did not confirm the interaction with H3 histone tail
(data not show).
87
Fig 35. The PHD finger orientation. (A) Cartoon representation of the model of NSD1-P5C5 in complex with H3 histone tail (in
blue). The model has been generated through the superposition with the structure of NSD3-P5C5 in complex with the H3 histone tail
(B). (B) Cartoon representation of NSD3-P5C5 in complex with H3 histone tail. (C) Cartoon representation of Dpf3b-PHD12 in
complex with H3 histone tail. (D) Cartoon representation of MOZ-PHD12 in complex with H3 histone tail
5.2.1 NSD1-P5C5 in the Sotos Syndrome
In the context of Sotos Syndrome NSD1  missense mutations occur in the catalytic SET
domain, PWWP, and PHD finger modules, suggesting that each domain has a role in the
pathology.  The  crystal  structure  of  the  SET  domain  of  NSD1  and  the  histone  lysine
methyltransferase activity assays show that the missense mutations within the SET domain
are responsible for the loss or reduction of the histone lysine methyltransferase activity of
NSD1, which may induce aberrant lysine methylation pattern during development (Qiao et
al 2011). 
The NSD1-P5C5 structure allowed us to rationalize the impact of the Sotos mutations on the
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tandem  domains  showing  that  Tyr2142Asn,  Arg2152Gln,  Phe2182Ile,  His2143Glu,
His2143Tyr,  His2164Arg  and  His2206Arg,  compromise  the  protein  fold.  The  histidine
mutations, affect the zinc ion binding sites, destabilizing the protein structure  (His2143Glu,
His2143Tyr,  His2164Arg)  or  partial  alterating  the  secondary  structural  element
(His2206Arg).  Interestingly, the Tyr2142 and  Phe2182  mutations, that  involve important
residues of the hydrophobic core have a detrimental effect on the protein structure leading to
a complete unfolding of the tandem domain. Of note only one mutation, Arg2152Gln, that is
located in a solvent exposed patch on the surface of NSD1-P5C5, does not affect the protein
fold. The misfolding mutations probably determine the loss of functions associated with the
protein domain and thus alter the biological role of NSD1, such as cellular localization or its
recruitment on the chromatin. Conversely, the mutations that only partially affect the protein
fold or are solvent exposed could compromise the interaction with other regulatory partners.
To verify this hypothesis we have characterized the effects of the NSD1-P5C5_His2206Arg
and NSD1-P5C5_Arg2152Gln pathological  mutants on the interaction with the zinc finger
module C2HR of the corepressor Nizp1 with (see Results, section 4.3.4). The first disease-
associated  mutation  (NSD1-P5C5_His2206Arg)  is  localized  near  the  Nizp1-C2HR
interaction  region  and  probably  destabilizes  this  binding  event  (see  Result  3.3.4).  The
second pathological substitution (Arg2152Gln) is far from the zinc finger binding surface,
thus  it  might  not  have  impact  on  Nizp1-C2HR  interaction,  as  indicated  by  the  NMR
titration. We  hypothesise that the protein surface near the  Arg2152 is involved with the
recruitment of other specific NSD1 cofactors that we aim to identify in future by proteomic
studies. 
In the last years, several disease-associated mutations affecting the PHD fingers have been
structurally  and functionally characterized.  For  example,  the transcriptional  factor  AIRE
containing two PHD fingers  (PHD1 and PHD2),  normally localizes  in  punctate  nuclear
bodies, where it interacts with unmodified H3 histone tail through its AIRE-PHD1, and it
partners  with  a  number  of  chromatin  related  proteins  controlling  gene  expression  of  a
repertoire  of  peripheral-tissue  antigens  (PTAs)  to  mediate  deletional  tolerance,  thereby
preventing self-reactivity (Gaetani M et al 2012). Of note, the two PHD fingers are sites of
pathological  mutations  that  cause  the  autoimmune  disorder  APECED  (autoimmune
polyendocrinopathy  ectodermal  dystrophy)  (Lindsey  AB  et  al  2008).  In  particular,  the
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Cys443Gly mutation in AIRE-PHD2, impairs metal binding, completely destroying the fold
of  the  domain.  Herewith  it  compromises  the  nuclear  protein  localization  reducing  the
activation of AIRE-dependent genes (Gaetani M et al 2012). The mutation Val301Met in
AIRE-PHD1 it is solvent exposed and maintainers the structure fold. It  is localized in a
distinct region with respect to histone binding site, thus it does not affect the interaction
with H3 histone tail (Chignola F et al 2009). Conversely, it has a stronger impact on AIRE
interactome reducing the interactions with protein partners involved in the transcriptional
activation (Gaetani M et al 2012). 
These observations support the notion that different surface in a PHD finger are involved in
several protein interactions. We therefore expect that the  Arg2152Gln mutation will affect
NSD1 interactome, thus compromising the recruitment of important co-factors to chromatin
and possibly affecting  the transcriptional events regulated by NSD1. In future proteomics
studies comparing  NSD1 interactome with its wild-type and mutated form will give useful
insights in NSD1 function.
5.3 Nizp1-C2HR is a zinc finger module with unusual Zn2+ coordination 
No direct interactors of NSD1 are known except Nizp1 that interacts with NSD1-P5C5 via
its C2HR domain (Nielsen AL et al 2004). Nizp1-C2HR is an atypical Cys2His2-type zinc
finger in which the fourth chelating residue is substituted by arginine residue (Arg427).
Zn2+  ion is crucial for the protein fold as the zinc depletion unfolds the domain. Nizp1-
C2HR has a typical zinc finger fold consisting of an α-helix (residue Arg417-Arg425) and a
β-hairpin  (β1  and  β2  residues  Tyr405-Cys407  and  Gly411-Phe414,  respectively)  hold
together by one zinc ion. The small hydrophobic core is composed by Phe417, Phe420 and
His423. The Trp416 is not conserved in the others Nizp1 zinc fingers, and it is partially
solvent  exposed  suggesting  its  possible  involvement  in  a  protein  binding  event.  The
electrostatic potential of Nizp1-C2HR on the solvent exposed side of the α-helix is positive
suggesting  a role as binding region. 
The metal binding site is composed by three ligands, two Cys (Cys407 and Cys410) and one
His (His423). This kind of coordination is not unusual in zinc finger modules: in several
domains  the  fourth zinc  ligand is  not  necessarily  an  His  or  Cys residue and it  can  be
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substituted by an aspartate or glutamic acid. In other cases a water molecule can function as
fourth Zn2+ coordinating ligand.  For  example,  in the  AFV1p06-zinc finger  structure the
fourth ligand of  the  zinc  ion is  the  side-chain oxygen atom of  the  carboxylic  group of
glutamic acid residue (Guilliere F et al 2013), while in NEMO zinc finger a water molecule
coordinates the Zn2+ ion upon mutation of a cysteine into phenylalanine,  indicating that
mutations of Zn2+chelating residues not always lead to domain unfolding (Cordier F et al
2008). 
In conclusion, three zinc chelating residues can be sufficient to stably coordinate metal ion.
From our  structure  and  NOE  data,  it  was  evident  that  the  C-terminal  region  (Ser426-
Lys434) is  disordered. The backbone carbonyl oxygen of the Arg427 is far from the metal
binding site. Moreover mutation of this residue into alanine produces a well folded protein
indicating the side-chain of the residue in position 427 is not involved in Zn2+ binding. We
exclude also that Glu429 and His433 coordinate zinc as they are structurally distant from
the Zn2+ binding site.  We observed that  Asn409 is near the zinc binding site, however, its
replacement by Ala residue did not affect the protein fold, suggesting that it is not involved
in metal coordination. We speculate that a water molecule could be close to the zinc ion thus
acting as a fourth ligand,  a  common situation in catalytic zinc-binding site  of  enzymes
(Sankaranayanan  R  et  al  1999).  We next  mutagenized  Arg427  into  a  His  residue:  the
presence of  the zinc-ligand in this  position determines the formation of  a classical  zinc
binding  site  (Cys2His2).  The  structure  of  the  mutant  calculated  by  NMR spectroscopy
shows that it is similar to the wild type one, and the histidine residue induces an additional
helical turn that extends the alfa-helix after the position 427. 
Taken together, our data are consistent with those previously published on other the zinc
finger modules. The biophysical characterization of several Cys2HisX mutants ( X=Asp,
Asn,  Glu,  Arg or Ala) showed that  the fourth chelating residue is  not essential for  zinc
binding and that three zinc-ligands are sufficient to maintain the zinc finger fold and its
functionality.  An  example  of  Zn2+ coordination  by  only  three  ligands  is  given  by  the
transcriptional  repressor  BKLF.  It  contains  a  tandem  array  of  zinc  finger  domains
(Cys2His2) whereby the last zinc finger module is involved in the DNA binding (Simpson
RJ et al 2003). In this module, the substitution of the fourth coordinant (Histidine) with an
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aspartate, glutamate, asparagine, glutamine, alanine, and arginine did not affect the metal
binding  and the  ability  to  recognize  the  DNA sequence,  thus  maintaining  its  ability  to
promote the transcriptional activation (Simpson RJ et al 2003). 
We  have  characterized  the  interaction  between  Nizp1-C2HR_Asn409Ala  and  Nizp1-
C2HR_Arg427Ala/His mutants  with  NSD1-P5C5 (see Results  section 4.3.5).  The NMR
titrations show that the alanine substitutions  did not affect the binding with NSD1-P5C5.
Interestingly, also the Arg427His substitution maintains its interaction with NSD1-P5C5 as
the wild type domain.  This latter  result  is not in agreement with the two hybrid assays
published  by  Nielsen  et  al in  which  the  Arg427His  substitution  seems  to  hinder  the
interaction with NSD1-P5C5. This point will be further discussed in the next section.
5.4 NSD1-P5C5 binds Nizp1-C2HR: identification of  the binding surfaces by NMR
titrations
5.4.1 NSD1-P5C5 binding site mapping
We performed NMR titrations to establish the interaction surfaces between NSD1-P5C5 and
Nizp1-C2HR. In NSD1-P5C5, the NMR chemical-shift mapping shows that the binding site
is  localized at  the  interface  between  the  two PHD fingers  involving  residues  Phe2122,
Ser2123,  Cys2124,  Ser2132,  Cys2133,  His2143,  Tyr2142,  Cys2146,  Leu2147,  Ala2152,
Trp2155, Glu2156, Glu2176 on  NSD1-PHD5, and residues Cys2178, Pro2179, Ser2180,
Ser2181,  Glu2204  and  His2205  on   NSD1-C5HCH.  These  data  indicate  that  both  the
modules, combined in a single functional unit, are involved in the Nizp1-C2HR recruitment
(see  Results  4.3.2).  This  concave  binding  surface  is  formed  by  hydrophobic  resides
surrounded  by  polar  residues  that  could  interact  with  the  zinc  finger  motif  through
hydrophobic and polar contacts, respectively. We observed that the surface involved in this
protein interaction is distinct from the predicted histone binding site (see Fig. 36). Further
structural studies are needed to clarify the role,  if any, of the NSD1-P5C5:Nizp1-C2HR
complex in the recognition of histone tails.
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Fig. 36. Model of NSD1-P5C5:Nizp1-C2HR in complex with the H3 histone tail. Cartoon representation of the tertiary complex
in which the NSD1-P5 and NSD1-C5 are colored in light green and dark green, respectively. The Nizp1-C2HR domain and histone
tail are  colored in orange and blue, respectively.
In the literature other cases have been described in which the combination of PHD fingers
or PHD finger and other epigenetic modules (such as bromodomains), function together to
read epigenetic marks and to interact with non-histone proteins. An example is given by
MLL1 PHD3-bromodomain. In this case the PHD3 finger and the bromodomain adopt a
compact fold whereby the bromodomain regulates the function of the PHD3 that can bind
simultaneously,  through distinct  surfaces,  both the histone H3K4me2/3  markers  and the
suppressor factor Cyp33 . In the apo-state the bromodomain increases the binding affinity of
the  PHD3 finger  for  H3K4me3 by  20  fold.  In  the  presence  of  Cyp33 the  interactions
between the PHD3 and bromodomain are disrupted and the PHD finger can interact with the
RNA recognition motif (RRM) of Cyp33. The PHD3:Cyp33 complex is also involved in the
interaction  with  H3K4me2/3  and  the  dissociation  constant  for  the  histone  peptides  is
doubled when compared to the PHD-bromodomain alone. The ability of PHD3 to bind both
histone  peptides  and  non-histone  protein  reinforces  the  concept  that   PHD fingers  can
function  not  only  as  reader  but  also  as  mediators  of  interactions  whit  other  regulatory
proteins.
5.4.1 Nizp1-C2HR binding site mapping
The Nizp1-C2HR region involved in the interaction with NSD1-P5C5 comprises part of the
β2-strand (Lys412,  Phe414),  the  loop (Trp416)  and the short  alfa-helix  (Arg417,  Val418,
Asn419, Phe420, Arg422 and His423). The strongest CSDs affects the alfa-helix (Arg417-
His423) indicating that this structural element is fundamental for the interaction (see Results
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4.3.3). 
Usually, in  zinc finger modules the alfa-helix has both DNA and protein binding activity.
For example  the human transcriptional regulator FOG-1 (‘Friend of GATA-1’) contains
nine classical zinc finger domains, whereby five can mediate protein–protein interactions
binding the N-terminal GATA-1 transcription factor (Fox et al. 1999; Simpson et al. 2004).
This  interaction  mediates  the  recruitment  of  FOG-1  to  gene  promoters  giving  rise  to
changes in gene expression that are essential for normal erythro and megakaryopoiesis in
mammals.  Structural  and  mutagenesis  studies  suggest  that  the  protein  binding  motif  is
localized on the α-helix of FOG zinc finger domains (Simpson et al. 2004; Garriga-Canut e
Orkin 2004), of note, the very same region is involved in DNA-binding  other FOG-1  zinc
fingers, highlighting the multitasking role of these domains (Gamsjaeger et al. 2007). 
5.4.2   HADDOCK model of the complex NSD1-P5C5:Nizp1-C2HR
Based on NMR chemical shift mapping data we have obtained a data driven docking model
(using HADDOCK) of the protein complex. In the model the short alfa-helix of Nizp1-
C2HR is localized at the NSD1-P5C5 interface and hydrophobic and polar contacts stabilize
the protein complex (see Fig 34). In particular, Ser2143, Asp2165 and Glu2204 of NSD1-
P5C5  interact  with  Asn419,  Arg422  and  Arg417  of  Nizp1-C2HR,  respectively.  The
interactions involve not only the residues on the Nizp1-C2HR α-helix but also Trp416 that
inserts its side-chain between the Phe2122 and Met2177 of NSD1-P5C5 at the PHD fingers
interface (see Result section 4.5). Further experimental data (side specific mutagenesis) will
be necessary to confirm these interactions. Moreover we aim to collect inter-protein NOE
restrains that will be introduced in new data driven docking calculations, that will improve
the quality of the model. Finally, a detailed analysis on the interactions between NSD1-
P5C5 and Nizp1-C2HR will have to await the solution of  the protein complex by X-ray
crystallography. 
5.5 The binding reaction between NSD1-P5C5 and Nizp1-C2HR is entropy-driven. 
The thermodynamic characterization of the interaction, by ITC experiment, shows that the
binding reaction has a Kd = (3,80±0,66) •106 M and  is entropy-driven (ΔH = +4.14 kcal/mol
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and TΔS = +14.19 kcal/mol). 
The  changes  in  entropy  are  related  to  solvent  effects  such  as  loss  of  ligand-solvent
interactions and solvent reorganization near the protein surface. Any binding event displaces
water molecules from the interaction surface. While the vast majority of water molecules in
the binding site are mobile and easy displaceable, some are tightly bound to the protein
structure.  The  release  of  these  bound  water  molecules  upon  ligand  binding  affects  the
thermodynamic  signature  of  the  binding  event  resulting  in  an  entropically  favourable
process  (Breiten  B  et  al  2013).  In  the  binding  reaction  the  entropic  and  enthalpy
contributions are related. This phenomenon, referred to as enthalpy/entropy compensations
describes the linear relationship between the change in enthalpy and in entropy. This means
that favourable changes in the binding entropy are balanced by opposite changes in binding
enthalpy  and  vice  versa,  resulting  in  very  small  changes  in  the  overall  free  energy
(Bronowska AK, 2012). 
In our case, the large positive entropy is compensated by small positive enthalpy changes.
Interestingly,  in  the  HADDOCK  model,  the  NSD1-P5C5:Nizp1-C2HR  complex  is
stabilized  by  several  polar  contacts  between  charged  residues.  The  side-chain  of  these
residues are likely to form hydration shells with the water molecules in the free form. Thus,
it  appears that the thermodynamic parameters observed in the formation of the complex
reflect both the release of water molecules from the binding site and the desolvation of the
ligand. Similar mechanisms are observed in other biomolecular interactions, such as the
interaction  between  the  peripheral  subunit-binding domain  (PBSD)  of  the  dihydrolipoyl
acetyltranferase  and the dihydrolipoyl dehydrogenase (Jung H et al 2002), in which the
excluding water from the binding surface serves as driving force in molecular association.
5.6 Hypothesis on NSD1 gene regulation mechanism
Berdasco  at al  2010 showed that the silencing of NSD1 is involved both in up-regulation
and in down-regulation of several development and differentiation genes. This duality is
probably linked to NSD1 ability to methylate both H4K20 and H3K36 (Rayasam GV et al
2003). The H4K20 methylation appears to be associated with transcription silencing and the
H3K36 methylation has been found primarily in active genes throughout the gene body,
even though it is also present in inactivated genes, depending on the context and genome
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loci. In this scenario, we can speculate that all the NSD1 epigenetic modules interacting
with  histone  post-transcriptional  modifications  and  non-histone  proteins  can  direct  the
NSD1 histone methylation activities, depending on cellular context.  
NSD1 is member of NSD protein family that contains other two proteins called NSD2 and
NSD3, that possess a C-terminal tandem domain. However, these domains fail to interact
with Nizp1, suggesting that this protein-protein interaction is specific for NSD1 (Nielsen at
al 2004). Several data are available on the NSD2 methylation activity and the role of its
PHD fingers (Kuo JA et al 2011). This NSD protein shows a single methylation specificity
for H3K36. Experimental data indicate that the PHD1,2,3 are involved in recruitment of
NSD2 on the chromatin, and in particular only  PHD2 is fundamental for the methylation of
H3K36, while the P5C5 tandem domain has no impact on histone methylation. The NSD1-
PHD1,2,3  share  a  high  homology  protein  sequence (40%)  with  NSD2-PHD1,2,3.  It  is
conceivable  that  also  the  first  three  NSD1-PHD fingers  contribute  to  NSD1 chromatin
localization and that the interaction of NSD1-P5C5 with the repressor Nizp1 via its C2HR
motif regulates methylation activity of NSD1 to specific promoters.
5.7 Conclusions and future works
NSD1 is a versatile protein that can act  as coactivator and corepressor.  This diversified
function is probably due to the presence of  different chromatin related domains that can
have opposite outcomes, depending on the cellular  context.  
Here,  we  have  investigated  the  structure  of  the  tandem  PHD  finger  NSD1-P5C5  and
characterized the structural effects of Sotos pathological mutations by NMR spectroscopy.
We have also characterized its interaction with Nizp1-C2HR, an unconventional Zinc-finger
motif,  using  a  combination  of  NMR,  ITC and  computational  methods.  NMR titrations
showed  that  Sotos  mutations  affect  binding  to  Nizp1,  in  future  we  will  perform  ITC
measurements  to  thermodynamically  characterize  the  effects  of  these  mutations  on  the
binding. Finally the X-ray structure of the complex will give useful and definite insights
into the details of the interaction. Future work will be dedicated to the investigation of the
interplay between binding of Nizp-C2HR to NSD1-P5C5 and the interaction with histone
tails.
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